Speech therapy

Z21_SPEECH_THERAPY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — Z50.1 Hospital discharge: ICD-10 — Z50.1 Cause of death: ICD-10 — Z50.1 3 out of 7 registries used, show all original rules.	14087
4. Check minimum number of events None	14087
5. Include endpoints None	14087
6. Filter based on genotype QC (FinnGen only)	12155

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF9

NAME	Z21_SPEECH_THERAPY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	Z501
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z501
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z501
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Speech therapy based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12155	7427	4728
Unadjusted period prevalence (%)	2.45	2.64	2.17
Median age at first event (years)	59.74	57.73	62.90

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12571: Matched controls
125710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

320.2

3040

15166

R4135

NOMESCO Finland

Rehabilitation for hearing problems

6.2

317.9

556

929

R4120

NOMESCO Finland

Occupational therapy

3.3

313.4

1306

4281

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

309.4

5214

32431

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

307.7

3151

15420

Z71.9

ICD-10 Finland

Counselling, unspecified

5.9

307.7

2595

5313

SPAT1236

SPAT

Informing family of child’s disability

20.9

307.7

1341

713

Z50.1

ICD-10 Finland

Other physical therapy

+∞

307.7

12571

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

51.9

307.7

1271

272

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.3

307.7

3845

14779

Z01.7

ICD-10 Finland

Laboratory examination

2.9

307.7

3276

13431

N03AX16

ATC

[U] pregabalin

2.2

307.7

3736

19941

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

3.4

307.7

2256

7686

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

25.1

307.7

632

265

ZXD10

NOMESCO Finland

Scheduled procedure

2.4

307.7

5949

34485

A29

ICPC

General symptom/complaint other

2.9

307.7

2712

10960

Z3231

NOMESCO Finland

Registered nurse

3.0

307.7

5114

23273

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.3

307.7

637

1064

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

307.7

1593

5396

R4110

NOMESCO Finland

Physiotherapy

4.7

307.7

6637

24218

Z51.88

ICD-10 Finland

Other specified medical care

11.7

307.7

977

901

ZXA05

NOMESCO Finland

Left side

2.4

307.7

4066

20941

ZXA00

NOMESCO Finland

Right side

2.4

307.7

4332

22824

Z12.3

ICD-10 Finland

Special screening examination for neoplasm of breast

20.7

307.7

425

212

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

9.2

307.7

1423

1724

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

4.0

307.7

2021

5779

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.8

307.7

1977

4660

WZC30, ,

SPAT

3.3

307.7

1797

6099

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

16.1

307.7

823

543

Z01.3

ICD-10 Finland

Examination of blood pressure

16.6

307.7

698

444

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

3.8

307.7

1235

3506

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.7

307.7

1164

3345

XA402

NOMESCO Finland

ENMG

6.0

307.7

721

1258

Z3226

NOMESCO Finland

Physiotherapist

4.0

307.7

4245

14148

FP1E5, ,

SPAT

35.6

307.7

203

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

4.6

307.7

1069

2510

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

293.7

1538

5743

U28

ICPC

Limited function/disability (U)

9.1

286.5

355

402

A97

ICPC

No disease

2.2

283.6

3192

16963

-60

ICPC

Result test/procedure

3.4

283.4

1125

3572

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

280.7

3428

18793

L29

ICPC

Musculoskeletal sympt/complt other

2.7

279.6

1680

6736

SBA00, ,

SPAT

55.7

272.8

154

R1250

NOMESCO Finland

Evaluation of functional capability

4.9

270.4

621

1328

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

267.0

3796

21952

Z2221

NOMESCO Finland

Medical doctor

2.0

262.6

3937

23178

L28

ICPC

Limited function/disability (L)

2.1

259.6

3141

17082

B01AB05

ATC

enoxaparin; parenteral

1.9

256.1

4647

29164

-62

ICPC

Administrative procedure

4.5

243.4

616

1424

-69

ICPC

Other reason for encounter NEC

3.8

236.2

772

2153

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

235.0

2327

11645

N02AX02

ATC

tramadol; systemic, rectal

1.8

230.0

5960

41490

WX320

NOMESCO Finland

Spinalanesthesy

1.9

222.3

3617

21672

N06AX21

ATC

duloxetine; oral

2.3

219.1

1912

9057

WVA20

NOMESCO Finland

Medicine administration

4.1

216.9

620

1571

ZXE00

NOMESCO Finland

One hour or less

1.8

216.8

5194

35111

A01

ICPC

Pain general/multiple sites

2.4

212.9

1716

7847

A91

ICPC

Abnormal result investigation NOS

3.0

210.8

1012

3577

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

210.5

3351

19871

XCW10

NOMESCO Finland

Assessment of vision

5.3

207.7

425

821

R5599

NOMESCO Finland

Other rehabilitation service

4.1

205.3

582

1465

WX002

NOMESCO Finland

Sedation and analgesia

2.0

202.2

2829

16021

A27

ICPC

Fear of other disease NOS

3.0

198.1

953

3369

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

197.9

3256

19455

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

197.1

883

2997

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

193.8

992

3627

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

193.7

4463

29558

Z71.8

ICD-10 Finland

Other specified counselling

1.8

191.4

4631

31088

ZX120

NOMESCO Finland

Intravenous

2.4

190.8

1482

6649

Z2446

NOMESCO Finland

Social worker

2.8

185.6

1024

3894

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

185.3

2823

16392

WX402

NOMESCO Finland

General anaesthesia

1.9

182.7

3146

18999

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.1

181.5

1898

9620

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

180.6

2121

11232

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

178.9

1304

5677

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

174.7

1945

10085

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.0

173.4

802

2768

SPAT1285

SPAT

Provision of consultation response

2.9

172.5

891

3269

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

171.7

1045

4172

WX111

NOMESCO Finland

Local infiltration anesthesia

3.2

167.8

692

2233

A28

ICPC

Limited function/disability NOS

1.9

167.7

2697

15873

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

27.6

165.3

112

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.9

164.6

2337

13190

A02BC02

ATC

pantoprazole; systemic

1.7

163.3

8954

73800

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

161.5

607

1849

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.8

161.2

837

3077

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

159.2

1648

8290

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

159.2

3992

26741

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

158.4

1195

5271

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.5

156.8

1083

4588

UDC00, ,

SPAT

31.5

154.1

100

M01AB05

ATC

diclofenac; systemic, rectal

1.7

153.5

8303

67543

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

150.4

891

3503

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.7

148.9

839

3216

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

148.7

1036

4403

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

148.4

1578

8007

N02BE01

ATC

paracetamol; systemic, rectal

2.2

147.6

11420

102593

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

147.5

1779

9455

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

146.9

1576

8021

ZXD20

NOMESCO Finland

Day surgery

2.0

146.0

1782

9508

M48.0

ICD-10 Finland

Spinal stenosis

2.0

145.3

1851

10026

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.5

143.6

510

1497

R4130

NOMESCO Finland

Speech therapy

3.6

142.0

491

1416

L17

ICPC

Foot/toe symptom/complaint

1.7

141.1

4165

28925

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

141.0

3256

21186

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

140.4

5618

42040

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

139.6

1844

10103

XCH00

NOMESCO Finland

Eye pressure measurement

2.6

137.7

827

3270

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.2

136.5

234

382

TUPEI, ,

NOMESCO Finland

3.1

134.6

583

1933

WW200, ,

SPAT

0.5

133.4

1635

28290

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

4.7

133.1

316

692

AN1

Coronary angiography

2.0

132.6

1525

7945

M01AH05

ATC

etoricoxib; oral

1.6

132.6

7788

63434

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.3

132.1

348

827

K22

ICPC

Risk factor cardiovascular disease

2.4

130.2

929

3984

EAV, ,

NOMESCO Finland

4.3

129.6

336

789

Z65.9

ICD-10 Finland

Problem related to unspecified psychosocial circumstances

22.3

129.5

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.6

128.9

767

3017

S21

ICPC

Skin texture symptom/complaint

1.8

128.1

2151

12709

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

126.4

1640

8907

XF600, ,

SPAT

2.8

126.4

668

2473

XF602

NOMESCO Finland

Bloodpressure monitoring

5.0

125.7

272

551

ZXD35

NOMESCO Finland

Usual procedure

3.1

125.2

540

1785

R52.9

ICD-10 Finland

Pain, unspecified

2.0

124.7

1510

8004

H02AB07

ATC

prednisone; oral

1.9

123.3

1841

10471

N03AX12

ATC

[U] gabapentin; oral

1.8

123.1

2177

13053

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

122.3

2167

12997

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

119.5

983

4482

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

119.4

1974

11585

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.3

117.7

931

4175

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

6.4

117.6

196

311

L84

ICPC

Back syndrome without radiat pain

2.5

117.6

762

3122

Z00.8

ICD-10 Finland

Other general examinations

2.1

114.8

1140

5607

M01AH01

ATC

celecoxib; oral

1.7

114.1

2389

15005

SPAT1324

SPAT

Screening procedure

1.8

113.5

2016

12074

L12

ICPC

Hand/finger symptom/complaint

1.7

113.0

2306

14375

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

112.7

4595

34003

XQ845, ,

SPAT

18.7

112.5

XF404

NOMESCO Finland

Ambulatory ECG

2.1

111.0

1215

6197

ZXD05

NOMESCO Finland

Urgent procedure

1.6

110.0

3636

25615

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.2

109.9

1052

5097

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

109.8

1031

4958

KMAK, ,

NOMESCO Finland

1.5

109.7

5975

46979

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.1

109.7

311

781

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.3

109.6

184

294

A02BC05

ATC

esomeprazole; systemic

1.5

109.6

5135

39104

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

9.2

106.8

129

141

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.5

106.4

369

1065

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

106.3

5320

40999

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

106.1

2181

13598

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.0

105.9

478

1621

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

105.7

4673

35063

CL2S4, ,

SPAT

3.4

104.9

395

1202

B01AB10

ATC

tinzaparin; parenteral

1.9

103.4

1513

8516

-64

ICPC

Encounter/prob initiated by provider

4.1

102.7

290

726

M01AH02

ATC

rofecoxib; oral

1.8

102.5

1689

9865

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

101.7

1006

4931

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

101.7

3279

22887

ZXA10

NOMESCO Finland

Bilateral

1.7

101.6

2397

15489

ZY010

NOMESCO Finland

Hospital outpatient

2.5

101.2

676

2805

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.0

100.7

456

1549

BEF00, ,

SPAT

5.5

100.7

195

358

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

100.3

3549

25290

CS2P4

NOMESCO Finland

Optic nerve head imaging

5.2

99.9

207

404

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

99.7

949

4582

Catheterization and pressure measurement of the left side of the heart

4.1

99.5

282

708

M79.6

ICD-10 Finland

Pain in limb

1.5

99.3

5541

43463

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.9

98.2

293

763

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

98.2

2457

16102

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

98.1

4616

34943

S29

ICPC

Skin symptom/complaint other

1.6

98.1

2682

17972

XF402

NOMESCO Finland

ECG with work load test

1.9

97.6

1398

7805

SPAT1310

SPAT

Counselling related to known health issue

0.6

97.6

1819

28423

X58

ICD-10 Finland

Exposure to other specified factors

1.8

97.4

1855

11293

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

3.2

97.1

403

1301

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

96.6

1970

12222

F21, ,

ICPC

5.6

96.0

183

331

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

5.7

95.3

178

316

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

95.3

2332

15184

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

95.0

1123

5873

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

93.8

644

2706

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

93.2

266

671

WZC00, ,

SPAT

1.7

93.2

1941

12102

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.9

92.9

457

1625

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

92.3

1813

11119

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

92.1

1503

8733

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

7.3

92.0

135

187

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

91.7

3063

21465

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

90.5

3589

26105

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

90.2

908

4475

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

89.9

862

4170

J01DB01

ATC

cefalexin; oral

1.6

89.2

10161

91136

UJF32

NOMESCO Finland

Coloscopy

1.5

88.4

3317

23819

J01MA02

ATC

ciprofloxacin; systemic

1.5

88.1

4753

36755

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

88.0

1400

8066

M54.5

ICD-10 Finland

Low back pain

1.5

87.8

4488

34334

M25.5

ICD-10 Finland

Pain in joint

1.5

87.4

4036

30251

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.4

86.9

319

955

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.3

86.0

328

1006

D82

ICPC

Teeth/gum disease

0.6

85.2

2361

33766

Z2445

NOMESCO Finland

Psychologist

2.6

84.9

492

1905

XCK00

NOMESCO Finland

Perimetry

2.1

84.2

868

4313

N05CF01

ATC

zopiclone; oral

1.5

83.6

3942

29606

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

82.9

272

757

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

82.8

1379

8045

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

82.8

749

3538

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.5

82.6

536

2192

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

82.5

2404

16267

Z50.5

ICD-10 Finland

Speech therapy

4.1

82.4

230

571

N06AA09

ATC

amitriptyline; systemic

1.8

82.4

1258

7148

R03BA02

ATC

budesonide; inhalant

1.6

82.3

2186

14466

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

82.0

697

3210

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

81.8

2624

18148

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

81.3

1705

10616

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

81.3

928

4785

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

81.0

650

2922

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

81.0

614

2694

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

80.8

3252

23618

D01

ICPC

Abdominal pain/cramps general

1.7

80.1

1555

9478

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

79.1

1296

7518

R52.2

ICD-10 Finland

Other chronic pain

2.4

77.9

546

2313

C07AB07

ATC

bisoprolol; oral

1.4

77.5

5974

48958

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

77.2

1920

12481

Z46.7

ICD-10 Finland

Fitting and adjustment of orthopaedic device

11.2

76.9

N02AA05

ATC

oxycodone; systemic

1.6

76.2

2336

15957

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.7

76.2

425

1614

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

76.1

492

2008

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

76.0

555

2394

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

76.0

2227

15056

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

75.9

1408

8465

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.7

75.8

242

661

H02AB06

ATC

prednisolone; systemic

1.4

75.4

5765

47096

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

75.3

3182

23278

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

75.2

944

5028

R51.80

ICD-10 Finland

Headache

1.6

75.1

1856

12038

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

75.0

602

2705

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

74.4

698

3342

A02BC01

ATC

omeprazole; systemic

1.5

74.3

3266

24072

M03BX02

ATC

tizanidine; oral

1.4

74.1

7269

61926

M54.1

ICD-10 Finland

Radiculopathy

2.3

74.0

567

2498

C03CA01

ATC

furosemide; systemic

1.5

73.7

3728

28227

SPAT1151

SPAT

Treatment of major wounds

4.0

73.5

214

548

K07

ICPC

Swollen ankles/oedema

2.1

73.3

703

3395

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

73.3

1028

5678

L04AX03

ATC

methotrexate; systemic

1.8

73.1

1216

7080

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

72.5

8526

74838

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

72.5

401

1516

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.4

72.4

505

2134

J01FF01

ATC

clindamycin; systemic

1.5

72.1

3189

23506

A13

ICPC

Concern/fear medical treatment

3.0

72.1

334

1149

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

71.7

984

5394

A10AE04

ATC

insulin glargine; parenteral

1.8

71.6

1191

6932

R05

ICPC

Cough

1.5

71.5

3050

22316

R06.0

ICD-10 Finland

Dyspnoea

1.5

71.4

3348

24954

A10AB05

ATC

insulin aspart; parenteral

1.9

71.3

960

5231

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

71.2

622

2895

R03DC03

ATC

montelukast; oral

1.6

70.9

1982

13230

UKC02

NOMESCO Finland

Cystoscopy

1.6

70.8

1910

12641

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

70.0

611

2842

N06AX16

ATC

venlafaxine; oral

1.6

69.5

1643

10525

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

69.4

1274

7625

M01AX05

ATC

glucosamine; oral

1.5

69.2

2394

16755

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

68.9

4271

33466

ZX120, ,

SPAT

3.5

68.8

243

710

M03BX01

ATC

baclofen; systemic

3.1

68.7

288

935

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

11.7

68.7

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

68.6

4295

33706

K85

ICPC

Elevated blood pressure

1.6

68.3

2149

14725

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

68.2

1360

8328

EB1YA, ,

SPAT

5.6

67.8

129

233

WX199

NOMESCO Finland

Other local analgesia

2.4

67.8

500

2166

L20

ICPC

Joint symptom/complaint NOS

2.3

67.4

544

2449

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

67.4

924

5061

L01BA01

ATC

methotrexate; systemic

2.4

67.4

500

2172

U02

ICPC

Urinary frequency/urgency

1.6

66.8

1884

12584

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

66.6

701

3504

XX9XE

NOMESCO Finland

Other ultrasound examination

4.4

66.0

167

385

A10AE05

ATC

insulin detemir; parenteral

2.1

65.6

653

3197

L04AA13

ATC

[U] leflunomide

2.7

65.5

365

1385

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.0

65.2

294

996

CLA10, ,

SPAT

8.1

65.2

108

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

64.7

1550

9948

K07.60

ICD-10 Finland

Snapping jaw

2.1

64.7

614

2951

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.8

64.6

198

526

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.7

64.1

149

321

M01AC06

ATC

meloxicam; systemic, rectal

1.4

64.0

4270

33776

A06AD11

ATC

lactulose; oral

1.6

63.9

1767

11740

E66.8

ICD-10 Finland

Other obesity

2.1

63.8

673

3365

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

63.2

1245

7591

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

63.0

2895

21405

A04

ICPC

Weakness/tiredness general

1.6

62.9

1951

13303

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

62.9

522

10611

D11

ICPC

Diarrhoea

1.7

62.7

1390

8744

R53

ICD-10 Finland

Malaise and fatigue

1.4

62.6

3017

22504

GX1E5, ,

SPAT

3.5

62.1

217

630

L86

ICPC

Back syndrome with radiating pain

1.9

62.0

815

4399

J01MA12

ATC

levofloxacin; systemic

1.5

62.0

2181

15277

A08

ICPC

Swelling

1.9

61.7

782

4171

M35.7

ICD-10 Finland

Hypermobility syndrome

3.6

61.6

205

576

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.8

61.4

311

1123

A07AA02

ATC

nystatin; oral

1.9

61.2

756

3996

N02BF02

ATC

pregabalin; oral

1.9

61.0

873

4843

M02AA07

ATC

piroxicam; topical

1.4

60.9

4198

33316

M01AB55

ATC

diclofenac, combinations; oral

1.9

60.6

846

4656

VALMI, ,

NOMESCO Finland

1.5

59.9

2646

19385

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

59.9

1143

6903

A10BA02

ATC

metformin; oral

1.4

59.9

3310

25276

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

59.7

542

2560

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

59.4

792

4294

SPAT1059

SPAT

Spirometry at the office

2.0

59.4

636

3197

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

59.3

465

2068

N06AB10

ATC

escitalopram; oral

1.5

59.0

2236

15885

R52.1

ICD-10 Finland

Chronic intractable pain

4.2

59.0

160

389

L15

ICPC

Knee symptom/complaint

1.4

58.9

3051

23016

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

58.8

616

3071

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

58.8

1098

6591

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.2

58.8

497

2281

ACC51

NOMESCO Finland

Release of median nerve

1.8

58.6

944

5429

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

4.5

58.5

142

317

QCB10, ,

SPAT

3.5

58.5

202

582

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

58.4

865

4849

U05

ICPC

Urination problems other

2.0

58.3

696

3636

N06AX11

ATC

mirtazapine; oral

1.4

58.2

4019

31844

L13

ICPC

Hip symptom/complaint

1.5

58.1

2423

17540

NE1AA, ,

SPAT

2.9

58.0

281

991

D06

ICPC

Abdominal pain localized other

1.7

57.8

1102

6650

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

57.8

1137

6921

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

57.8

3198

24394

-50

ICPC

Medication/prescr/renewal

2.2

57.6

519

2443

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.7

57.4

1057

6318

XA400

NOMESCO Finland

EEG

5.2

57.4

118

229

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

6.4

57.4

150

OSTO, ,

NOMESCO Finland

4.1

57.3

158

389

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

57.3

500

2324

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

57.2

470

2131

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

57.1

516

2431

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

56.9

2293

16480

XA420

NOMESCO Finland

Extensive sleep examination

3.8

56.8

171

449

R02

ICPC

Shortness of breath/dyspnoea

1.6

56.4

1675

11286

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

4.3

56.3

145

339

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

56.3

1315

8369

B88.0

ICD-10 Finland

Other acariasis

6.2

56.3

153

M01AE02

ATC

naproxen; oral, rectal

1.3

56.3

6446

55157

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.1

56.0

242

800

B01AB04

ATC

dalteparin; parenteral

2.0

55.9

653

3385

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

55.8

1506

9925

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

55.8

1384

8940

Z47.8

ICD-10 Finland

Other specified orthopaedic follow-up care

4.5

55.5

134

298

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

55.3

361

1480

-44

ICPC

Preventive immunization/medic

1.8

54.9

967

5705

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.3

54.9

415

1817

N06AA12

ATC

doxepin; systemic

2.0

54.7

636

3292

S01BC05

ATC

ketorolac; ophthalmic

2.2

54.5

472

2186

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.1

54.5

525

2536

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

54.5

699

3741

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

54.4

7465

65460

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.4

53.9

269

6699

R03AC03

ATC

terbutaline; inhalant

1.6

53.7

1591

10703

K29

ICPC

Cardiovascular sympt/complt other

2.0

53.5

588

2982

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

53.3

527

2572

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.0

53.2

643

3372

S80.0

ICD-10 Finland

Contusion of knee

1.8

53.2

906

5293

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

53.0

239

810

-65

ICPC

Enc/prob init by other than pt/prov

5.3

52.8

107

205

KC1EE, ,

SPAT

4.7

52.7

122

262

-59

ICPC

Other therap proced/minor surg NEC

2.4

52.6

354

1471

A11

ICPC

Chest pain NOS

1.7

52.4

1075

6612

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.3

52.3

193

5526

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

7.9

52.3

N05AH04

ATC

quetiapine; oral

1.5

52.3

1921

13529

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

52.2

233

785

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

52.2

1586

10727

ZB0.1

ICD-10 Finland

Right side

12.1

52.1

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.0

52.0

625

3271

W19

ICD-10 Finland

Unspecified fall

1.6

51.9

1190

7529

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

51.6

390

1707

R42

ICD-10 Finland

Dizziness and giddiness

1.4

51.4

2805

21273

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

51.3

446

2070

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

51.2

329

1338

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.4

51.2

359

1520

R29

ICPC

Respiratory symptom/complaint other

1.8

51.1

826

4751

J01CF05

ATC

flucloxacillin; systemic

1.8

51.0

834

4814

A02BA02

ATC

ranitidine; systemic

1.5

50.7

2190

15913

J01AA02

ATC

doxycycline; systemic

1.4

50.6

9262

84326

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

6.2

50.4

140

N17

ICPC

Vertigo/dizziness

1.5

50.2

1577

10739

F29

ICPC

Eye symptom/complaint other

1.6

50.1

1274

8265

M24.2

ICD-10 Finland

Disorder of ligament

3.3

50.0

194

602

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.7

49.9

268

998

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

49.8

979

5951

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

49.6

964

5839

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

49.6

442

2071

D12

ICPC

Constipation

2.1

49.4

491

2400

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

49.4

924

5540

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.6

49.3

283

1090

LASKU, ,

NOMESCO Finland

4.1

49.2

136

336

XQ845

NOMESCO Finland

Dermatoscopy

2.6

49.1

282

1087

L04AB01

ATC

etanercept; parenteral

3.0

49.0

223

760

N05BA01

ATC

diazepam; systemic, rectal

1.5

48.8

1457

9807

R52.0

ICD-10 Finland

Acute pain

2.2

48.6

411

1885

R13

ICD-10 Finland

Dysphagia

1.7

48.6

861

5083

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

48.3

2208

16194

WX144

NOMESCO Finland

Subconjunctival anesthesy

3.6

48.3

159

444

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

48.1

1591

10947

A80

ICPC

Trauma/injury NOS

3.2

48.0

190

597

A62

ICPC

General and Unspecified, Administrative procedure

2.4

47.9

325

1356

-1, ,

NOMESCO Finland

1.4

47.7

3543

28192

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.2

47.7

188

589

IHA11, ,

SPAT

3.3

47.7

184

569

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.0

47.5

206

683

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

47.5

1158

7433

NG1EA, ,

SPAT

3.4

47.5

169

497

R03AC02

ATC

salbutamol; inhalant

1.3

47.4

6305

54536

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

47.4

583

3075

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

47.3

487

2411

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.9

47.3

223

775

S97

ICPC

Chronic ulcer skin

1.8

47.2

777

4491

R03BA05

ATC

fluticasone; inhalant

1.5

47.2

2012

14562

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.1

47.1

432

2047

D18

ICPC

Change in faeces/bowel movements

2.3

47.0

359

1578

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

47.0

623

3367

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.2

46.9

124

296

RT271, ,

NOMESCO Finland

8.5

46.7

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

46.7

954

5854

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

46.5

1435

20564

U07

ICPC

Urine symptom/complaint other

1.6

46.5

1049

6605

B01AF01

ATC

rivaroxaban; oral

1.5

46.2

1506

10324

P01AB01

ATC

metronidazole; oral, rectal

1.3

46.2

4515

37373

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

46.1

1276

8436

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

45.9

445

2155

L14

ICPC

Leg/thigh symptom/complaint

1.7

45.9

997

6217

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.7

45.8

144

390

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

45.8

354

1565

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

45.8

3010

23471

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

45.5

737

4237

SPAT1161

SPAT

Ultrasound examination of urinary bladder

5.4

45.5

169

N06AB04

ATC

citalopram; systemic

1.4

45.4

2312

17266

SPAT1104

SPAT

Monitoring of emergency patient

0.3

45.4

154

4602

R07.3

ICD-10 Finland

Other chest pain

1.6

45.3

1226

8062

K08.9

ICD-10 Finland

Disorder of teeth and supporting structures, unspecified

7.6

45.3

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

45.3

544

2846

M54.3

ICD-10 Finland

Sciatica

1.8

45.2

722

4134

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.7

45.2

1938

26112

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.6

45.2

272

1073

J01MA14

ATC

moxifloxacin; systemic

1.6

45.2

1021

6429

B01AC04

ATC

clopidogrel; oral

1.5

45.1

1865

13405

N03AX09

ATC

lamotrigine; oral

2.0

45.1

507

2592

L04

ICPC

Chest symptom/complaint

1.8

45.0

767

4476

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

44.9

5140

43433

N29

ICPC

Neurological sympt/complt other

2.6

44.8

264

1031

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.2

44.5

180

573

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

44.5

1985

14472

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

44.5

2346

17623

L03

ICPC

Low back symptom/complaint

1.3

44.5

3350

26657

N01

ICPC

Headache

1.6

44.4

1186

7773

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

3.0

44.3

193

642

ZB0.0

ICD-10 Finland

Left side

15.0

44.2

K28

ICPC

Limited function/disability (K)

2.4

44.1

300

1253

FL1AC

NOMESCO Finland

Left cardioangiography

2.7

44.1

231

850

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

44.1

764

4480

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

44.0

3070

24135

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

43.8

333

1462

L02

ICPC

Back symptom/complaint

1.6

43.6

1166

7643

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

43.5

278

1128

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

43.5

898

5522

R96

ICPC

Asthma

1.6

43.5

1179

7752

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

43.5

471

2376

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

43.4

6239

54254

RS221, ,

NOMESCO Finland

3.0

43.4

191

639

R06.5

ICD-10 Finland

Mouth breathing

1.6

43.3

979

6161

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

43.3

688

3934

ZX100

NOMESCO Finland

Oral

3.0

43.1

194

657

L04AB04

ATC

adalimumab; parenteral

2.5

43.1

272

1098

RD211, ,

NOMESCO Finland

0.2

42.9

2728

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

42.8

1008

6410

WX204

NOMESCO Finland

Axillary plexus blockaced

2.1

42.8

406

1950

NH3FA, ,

SPAT

4.5

42.7

104

233

QDB10, ,

SPAT

2.3

42.7

336

1496

J01FA06

ATC

roxithromycin; oral

1.3

42.7

4421

36771

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.7

42.4

132

355

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

42.4

1142

7498

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

42.2

498

2589

L09

ICPC

Arm symptom/complaint

1.9

42.2

592

3258

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

42.2

1221

8147

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

42.0

845

5161

K30

ICD-10 Finland

Functional dyspepsia

1.5

41.9

1306

8857

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

41.8

976

6190

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

41.7

685

3953

L91

ICPC

Osteoarthrosis other

2.4

41.3

279

1162

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.9

41.2

546

2949

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

41.2

1301

8846

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

41.0

1490

10430

T93

ICPC

Lipid disorder

1.6

40.9

898

5609

A92

ICPC

Allergy/allergic reaction NOS

2.2

40.8

348

1602

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

90.4

40.8

M53.2

ICD-10 Finland

Spinal instabilities

3.8

40.6

125

334

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

40.6

482

2511

B82

ICPC

Anaemia other/unspecified

2.2

40.3

367

1734

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

40.2

799

4864

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.6

40.1

132

369

L05

ICPC

Flank/axilla symptom/complaint

1.7

40.0

753

4515

M54.2

ICD-10 Finland

Cervicalgia

1.6

39.9

905

5698

XF606

NOMESCO Finland

Ortostatic test

3.6

39.9

134

380

J02AC01

ATC

fluconazole; systemic

1.3

39.8

4343

36283

J01FA09

ATC

clarithromycin; systemic

1.3

39.6

3408

27556

M01AX01

ATC

nabumetone; oral

1.9

39.5

491

2598

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

4.9

39.5

176

TUPKY, ,

NOMESCO Finland

3.9

39.4

117

305

R33

ICD-10 Finland

Retention of urine

1.7

39.3

851

5296

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

39.3

4140

34416

N28

ICPC

Limited function/disability (N)

2.6

39.1

233

915

S18

ICPC

Laceration/cut

1.3

39.0

5483

47285

D02

ICPC

Abdominal pain epigastric

1.7

39.0

730

4371

NG1AD

NOMESCO Finland

Knee CT examination

2.6

38.9

223

859

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

3.5

38.9

134

386

R83

ICPC

Respiratory infection other

1.4

38.9

2553

19819

TND33

NOMESCO Finland

Custom moulded brace or cast, wrist or hand

3.0

38.8

168

557

R35

ICD-10 Finland

Polyuria

1.7

38.8

792

4853

P01BA02

ATC

hydroxychloroquine; oral

1.6

38.7

936

5984

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

38.7

514

2778

N27

ICPC

Fear of neurological disease other

2.5

38.6

245

992

WX212

NOMESCO Finland

Femoral plexus blockade

2.2

38.4

319

1453

G04BD08

ATC

solifenacin; oral

1.7

38.4

774

4727

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

3.0

38.3

168

561

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.2

38.3

100

237

R06AX22

ATC

ebastine; oral

1.4

38.2

1818

13373

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.4

38.2

162

4354

N06AB06

ATC

sertraline; oral

1.5

38.2

1176

7945

M89.0

ICD-10 Finland

Algoneurodystrophy

3.6

38.2

126

353

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

38.1

815

5054

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

38.1

333

1549

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

37.9

2009

15057

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10903

89012

2.69

315.40

31.8

20.7

13.74

13.69

3.25

10842

87852

(4024509) Urine culture

1493

5332

3.04

309.64

2.2

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1397

4818

3.14

307.72

4.0

5.3

0.81

0.88

9.19

1369

4550

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11870

88802

7.04

307.65

29.9

21.8

331.43

331.79

g/l

4.21

11822

88309

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3127

11875

3.17

307.65

4.8

4.1

5.76

5.83

kpa

3.82

3075

11581

(3026782) Osmolality of Urine

4738

22308

2.80

307.65

4.4

3.0

559.33

523.91

mosm/kgh2o

21.15

4401

19504

(3030467) Casts [#/volume] in Urine by Automated count

6288

32863

2.83

307.65

4.6

3.4

0.31

0.45

e6/l

7.56

5372

23940

(3014051) Protein [Presence] in Urine by Test strip

6507

31824

3.17

307.65

4.8

3.0

0.04

0.06

0.37

474

707

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1038

1104

10.16

307.65

2.7

2.3

1.20

mmol/l

0.27

1030

1092

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4563

22600

2.60

307.65

4.3

4.1

222.67

441.81

ng/l

3.70

3538

17937

(3022096) Basophils/Leukocytes in Blood

7634

53791

2.07

307.65

8.6

6.7

0.69

0.68

0.39

7426

50256

(3018010) Neutrophils/Leukocytes in Blood

7660

53972

2.07

307.65

8.6

6.4

58.09

57.47

5.00

7543

51452

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6177

37728

2.25

307.65

3.3

3.4

32.55

34.78

u/l

1.25

6007

35486

(1761482) Bacteria [#/volume] in Urine by Culture

1921

2364

9.41

307.65

4.7

4.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1038

1127

9.95

307.65

2.7

2.3

105.76

105.46

mmol/l

0.84

1029

1115

(3000330) Specific gravity of Urine by Test strip

3127

5287

7.54

307.65

4.5

3.3

1.02

ratio

7.64

3006

4696

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1708

6164

3.05

307.65

2.9

3.1

0.66

0.62

6.43

1694

6143

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1902

5774

3.70

307.65

6.2

4.0

43.01

47.68

12.16

1878

5691

(3002582) Erythrocytes [#/volume] in Urine

6822

38171

2.72

307.65

4.7

3.5

57.90

79.43

e6/l

0.86

5846

29005

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1705

6241

3.00

307.65

2.9

3.2

1.11

1.23

5.23

1688

6214

(3018095) Leukocytes [#/volume] in Urine

7255

43321

2.60

307.65

5.3

4.1

106.99

105.47

e6/l

0.06

5921

30437

(3008037) Lactate [Moles/volume] in Venous blood

1719

2563

7.61

307.65

4.2

3.1

1.57

1.60

mmol/l

0.41

1699

2486

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2196

9314

2.65

307.65

3.4

3.0

199.68

200.48

ng/l

0.02

1965

8552

(3038515) Glucose [Moles/volume] in Venous blood

1671

2079

9.12

307.65

4.1

3.3

7.50

7.62

mmol/l

0.66

1652

2018

(36304419) Bacteria [Presence] in Urine

5531

31302

2.37

307.65

4.5

3.3

234.21

160.65

estimate

0.13

162

100

(3016750) Collection duration of Urine

420

496

8.73

307.65

2.3

495.20

500.11

min

0.39

408

341

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2386

9658

2.81

307.65

2.6

2.5

0.39

0.45

e6/l

0.55

2351

9236

(3004775) Volume in Urine collected for unspecified duration

570

699

8.49

307.65

2.9

2.2

591.57

673.26

4.04

510

432

(3000850) Epithelial cells [#/volume] in Urine

4706

26456

2.24

307.65

3.6

2.8

5.50

5.67

e6/l

0.44

4434

24062

(3002032) Base excess in Venous blood by calculation

3189

11521

3.37

307.65

4.8

4.1

2.18

1.80

mmol/l

7.46

2755

10110

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4314

18712

2.99

307.65

3.6

3.2

2.81

2.73

e6/l

0.21

2983

8872

(3021589) Normoblasts [#/volume] in Blood

7765

49959

2.45

307.65

12.7

12.0

0.00

e9/l

0.02

6778

40435

(3027273) Bicarbonate [Moles/volume] in Venous blood

1912

5145

4.20

307.65

4.7

3.5

25.54

25.19

mmol/l

4.04

1885

4973

(3041354) Potassium [Moles/volume] in Venous blood

1039

1127

9.96

307.65

2.7

2.3

4.10

4.05

mmol/l

2.08

1031

1115

(3012544) pH of Venous blood

3201

12011

3.23

307.65

4.8

4.1

7.38

5.55

2492

6761

(3002030) Lymphocytes/Leukocytes in Blood

7781

55036

2.09

307.65

8.7

6.6

26.93

27.52

5.29

7587

52038

(3024354) Oxygen [Partial pressure] in Venous blood

2821

9870

3.40

307.65

4.3

3.4

4.51

kpa

0.05

2773

9604

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4515

20634

2.85

307.65

3.7

3.1

1.22

1.28

e6/l

0.12

3249

10804

(3004119) Hemoglobin [Mass/volume] in Venous blood

2384

7161

3.87

307.65

4.0

3.5

129.32

128.25

g/l

1.46

2358

6954

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1471

5285

3.02

301.50

4.0

5.1

1.46

1.62

7.36

1439

5006

(3006504) Eosinophils/Leukocytes in Blood

7546

53823

2.01

299.35

8.6

6.6

2.81

2.85

0.80

7352

50322

(3019069) Monocytes/Leukocytes in Blood

7540

53965

1.99

293.68

8.6

6.7

8.75

8.89

4.33

7327

50491

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

145

14296

0.09

278.49

3.8

5.1

30.53

32.78

2.00

120

9463

(40758558) Short blood count panel - Blood

5325

34793

1.92

261.23

9.3

6.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

189

13877

0.12

248.34

4.4

7.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4037

25400

1.87

211.46

2.0

1.8

1.23

1.26

mg/l

0.17

3396

19765

(3029937) Albumin [Presence] in Urine by Test strip

1853

34482

0.46

207.72

3.1

4.4

0.01

0.00

estimate

0.59

1130

11617

(3037467) Urinalysis macro (dipstick) panel - Urine

9445

77331

1.89

198.34

6.5

4.8

1.13

2.28

—

122

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3074

18015

1.93

198.14

2.2

2.1

29.71

29.68

0.08

3025

17527

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2165

11226

2.12

196.46

2.9

2.5

39.76

43.60

u/l

0.21

1847

9482

(3032080) INR in Blood by Coagulation assay

7174

54385

1.74

192.94

15.0

15.7

1.25

1.27

inr

2.25

6393

45344

(3013115) Eosinophils [#/volume] in Blood

7761

60546

1.74

184.37

8.6

6.6

0.19

e9/l

1.52

7077

52525

(3013826) Glucose [Moles/volume] in Serum or Plasma

8475

67890

1.76

181.96

6.1

5.2

6.94

6.71

mmol/l

12.53

8149

64554

(3019198) Lymphocytes [#/volume] in Blood

7690

59955

1.73

181.88

8.5

6.4

1.88

1.90

e9/l

0.33

6996

52415

(3001604) Monocytes [#/volume] in Blood

7540

58706

1.71

176.80

8.4

6.3

0.60

0.59

e9/l

3.13

6748

50093

(3013650) Neutrophils [#/volume] in Blood by Automated count

8243

65767

1.74

176.71

12.1

9.8

4.23

4.13

e9/l

3.09

7455

56775

(3006315) Basophils [#/volume] in Blood

7555

58888

1.71

176.09

8.4

6.4

0.04

e9/l

2.58

6805

50234

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

669

2107

3.30

168.80

2.4

1.9

0.84

0.85

nmol/l

0.16

605

1779

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1333

6049

2.35

166.03

1.6

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6926

53346

1.66

163.16

3.0

2.8

—

estimate

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7606

60083

1.67

161.83

8.9

7.4

1.22

1.21

mmol/l

11.77

7405

51678

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1043

4324

2.54

158.18

2.2

2.3

9.92

10.19

g/l

1.16

988

3792

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9831

83670

1.80

155.12

5.6

4.5

12.80

12.70

mm/h

0.28

9629

78180

(3044640) Blood type and Crossmatch panel - Blood

5215

37680

1.66

155.07

2.8

2.5

—

(40761536) Microorganisms panel - Urine sediment

155

9326

0.16

149.99

3.7

4.2

—

(3006270) Folate [Moles/volume] in Blood

372

856

4.45

147.29

1.2

281.54

359.40

nmol/l

9.64

271

726

(3033658) Prothrombin time (PT) actual/Normal

4262

29613

1.66

145.02

5.4

4.2

89.16

89.29

0.13

4209

28948

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6685

52223

1.60

138.79

2.4

2.2

92.19

96.25

pmol/l

12.66

3784

27444

(3042936) Bacteria identified in Isolate by Culture

2684

16689

1.77

135.66

2.6

2.0

—

(3000991) Gas panel - Venous blood

1891

10552

1.93

135.28

9.7

9.1

—

(3015736) pH of Urine

6301

48869

1.58

132.34

4.6

3.6

6.38

6.23

28.98

4480

26615

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1094

5035

2.28

130.51

2.2

2.3

3.73

3.69

g/l

0.48

1056

4558

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1094

5044

2.28

129.94

2.2

2.3

4.25

4.21

g/l

0.62

1059

4567

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1094

5051

2.28

129.49

2.2

2.3

7.54

7.41

g/l

1.76

1059

4567

(3022948) Iron [Moles/volume] in Serum or Plasma

3153

20859

1.68

125.96

3.2

2.6

12.38

12.77

umol/l

2.53

3053

19334

(3007853) Bacteria identified in Skin by Aerobe culture

2279

13789

1.80

125.21

2.2

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

760

3019

2.62

125.15

3.7

3.4

8.00

8.19

kpa

2.11

749

2944

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2969

19459

1.69

122.31

3.1

2.6

2.32

g/l

0.12

2879

17887

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11739

107915

2.33

122.28

25.3

17.0

24.14

24.67

mg/l

1.03

10430

89777

(4094501) Cardiovascular stress test using bicycle ergometer

747

3013

2.57

119.10

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1882

10924

1.85

117.81

8.1

7.8

1.29

1.34

mmol/l

1.15

1855

10696

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

649

2473

2.71

115.97

2.7

2.3

47.24

108.40

ug/min

6.20

544

1394

(3024928) Oxygen saturation in Venous blood

715

2935

2.52

109.73

3.3

3.5

60.74

61.31

0.25

694

2841

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1198

6113

2.06

109.19

2.7

2.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9934

87520

1.64

106.78

10.0

8.5

82.41

79.97

u/l

4.43

9745

83094

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7444

61627

1.51

104.47

7.2

6.7

11.23

11.53

umol/l

1.29

7276

58702

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2711

18043

1.64

102.52

3.1

2.7

21.22

22.17

3.50

2646

16679

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1312

7063

1.96

102.50

4.9

4.3

24.45

24.23

mmol/l

1.64

1295

6984

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

923

4368

2.20

102.08

2.9

3.6

520.42

2105.71

u/ml

1.56

772

3761

(3041096) Erythrocytes [Presence] in Urine by Automated

4303

31980

1.53

100.40

5.6

3.5

0.05

0.33

estimate

3.37

1068

9950

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

368

1105

3.40

99.81

4.0

3.6

—

(3021440) Promyelocytes/Leukocytes in Blood

1692

10115

1.78

94.38

4.9

4.5

0.09

0.12

0.53

360

2872

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

11294

103915

1.85

93.31

23.7

16.6

80.00

79.20

ml/min/173m2

3.83

11011

96367

(3019225) pH of Specimen

484

11682

0.39

92.88

4.2

4.4

7.35

7.36

0.47

447

8316

(3022621) pH of Urine by Test strip

1565

9209

1.80

91.93

3.5

2.7

6.03

6.07

1.34

1373

6161

(3021901) Oxygen saturation in Capillary blood

602

2475

2.50

91.83

2.9

3.1

88.83

89.75

2.06

591

2411

(3024561) Albumin [Mass/volume] in Serum or Plasma

6538

53517

1.46

91.28

5.5

5.1

35.75

35.48

g/l

3.57

6345

50054

(3019550) Sodium [Moles/volume] in Serum or Plasma

11818

110597

2.14

90.17

27.5

20.2

139.66

139.67

mmol/l

0.14

11761

108517

(3017181) Myelocytes/Leukocytes in Blood

1731

10588

1.74

88.70

4.9

4.4

0.75

0.98

2.79

400

3338

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2128

13772

1.66

88.26

2.8

8.25

8.60

umol/l

0.30

1906

12004

(3023103) Potassium [Moles/volume] in Serum or Plasma

11822

110808

2.12

87.22

27.8

20.3

3.97

mmol/l

0.53

11754

108553

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

723

3297

2.27

87.21

2.4

0.00

g/l

-0.00

688

3069

(42870588) Differential panel, method unspecified - Blood

5052

39696

1.46

85.36

7.3

6.4

—

4.26

—

(3023368) Bacteria identified in Blood by Culture

4320

33055

1.47

83.24

5.1

4.4

—

(3037522) Nuclear Ab [Titer] in Serum

2399

16236

1.59

82.24

1.5

1.4

463.05

511.97

titre

0.70

512

3543

(3045424) Erythrocytes [Presence] in Urine

136

6036

0.22

81.71

2.2

0.00

0.18

estimate

0.70

1833

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

547

2292

2.45

79.97

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

547

2292

2.45

79.97

1.4

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

117

162

7.28

79.76

5.8

6.0

8.91

8.12

mmol/l

0.93

117

162

(3018418) pH of Serum or Plasma

4661

36413

1.45

79.49

5.0

4.3

7.39

7.40

16.94

3778

25949

(3020779) Urea [Moles/volume] in Serum or Plasma

1713

10830

1.67

76.80

8.0

7.5

10.00

10.07

mmol/l

0.16

1663

10345

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1268

7401

1.79

75.69

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2098

14105

1.59

73.00

2.1

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

724

3546

2.11

72.75

2.4

2.3

0.00

g/l

0.83

687

3080

(3052851) Hemolysis interference index of Serum or Plasma

682

3277

2.14

72.02

3.0

3.3

1.16

2.06

index

5.34

429

1638

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1237

7311

1.77

70.50

9.9

9.6

24.39

24.30

mmol/l

0.44

1215

7164

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1923

12816

1.59

69.07

3.6

4.3

14.40

25.37

ug/l

1.67

1608

10458

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

734

3683

2.05

69.06

2.4

2.3

0.02

0.03

g/l

0.47

698

3293

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8363

73575

1.41

67.03

3.6

3.4

51.68

49.26

u/l

1.43

8111

68841

(3025159) Blasts/Leukocytes in Blood

1588

10229

1.63

65.37

4.8

4.6

0.55

0.32

0.26

264

2755

(1761868) Lipid panel - Serum or Plasma

5008

40631

1.39

64.67

4.5

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

7177

61725

1.38

64.64

5.3

4.1

0.04

0.45

estimate

1.58

1428

12150

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4560

36486

1.39

63.75

3.5

3.2

1537.04

1449.74

ng/l

0.63

4180

31565

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11998

114437

2.06

62.80

30.6

22.2

78.70

77.62

umol/l

2.38

11947

113101

(3021601) Nitrite [Presence] in Urine by Test strip

7049

60594

1.37

62.80

5.3

4.1

0.00

estimate

0.19

1490

12504

(3044889) 12 lead EKG panel

8779

78240

1.40

62.65

3.9

4.2

0.00

2687.09

—

161

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1271

7870

1.68

60.77

2.2

2.4

23.51

22.59

au/ml

0.11

834

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2885

21443

1.45

60.65

1.4

1.3

34.40

34.50

iu/ml

0.01

878

6601

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2707

19890

1.46

60.44

1.4

1.3

13.38

11.80

u/ml

0.25

1151

7634

(3031040) Bacteria [#/volume] in Urine by Automated count

8447

74991

1.39

60.21

6.1

5.0

2945.79

2319.56

e6/l

0.20

1080

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4573

36907

1.38

59.46

2.5

2.2

185.33

208.58

u/l

1.12

4413

34841

(3035350) Ketones [Presence] in Urine by Test strip

7090

61308

1.36

59.04

5.3

4.1

10.65

3.34

estimate

1.66

1593

12840

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10889

101567

1.54

56.67

6.0

5.6

1.91

1.93

mu/l

1.09

10670

93877

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6269

53416

1.35

56.29

2.8

2.5

78.22

1779.08

nmol/l

0.50

6052

48213

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6296

53688

1.35

56.20

3.7

3.1

129.03

128.95

ug/l

0.01

6103

49905

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1393

9033

1.61

55.19

1.8

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3662

28792

1.38

54.79

2.8

2.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

447

2029

2.25

54.26

4.4

3.8

28.89

38.94

u/ml

1.35

442

1962

(3015235) Bicarbonate [Moles/volume] in Capillary blood

760

4198

1.86

53.70

3.1

2.9

25.24

24.84

mmol/l

1.63

750

4126

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

638

3334

1.96

53.32

1.4

1.5

11.53

15.13

iu/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

535

2633

2.08

52.86

1.3

1.2

36.44

45.92

u/ml

0.53

262

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

634

3318

1.96

52.76

1.5

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2105

15087

1.47

52.48

2.1

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1437

9522

1.57

51.75

4.6

3.9

92.15

90.85

ng/l

0.18

1261

8175

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

3357

0.17

51.74

1.2

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11867

113459

1.82

51.40

15.8

12.6

25.81

u/l

0.00

11782

110103

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

834

4810

1.79

51.11

2.4

2.3

3.05

2.90

g/l

4.37

796

4331

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

252

901

2.83

50.72

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

585

3019

1.98

50.67

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

110

224

4.95

50.66

1.2

1.3

1.19

1.17

mmol/l

1.40

110

224

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10807

101101

1.49

50.61

5.1

4.4

1.31

1.29

mmol/l

1.77

10469

92601

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

252

903

2.83

50.51

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

248

885

2.84

50.10

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

585

3031

1.98

50.09

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

580

2997

1.98

50.05

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

12099

116535

2.02

49.18

36.0

26.0

132.86

134.21

g/l

21.05

12084

115295

(3007461) Platelets [#/volume] in Blood

12095

116484

2.01

49.16

35.7

25.9

251.30

251.37

e9/l

0.04

11997

114080

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12097

116516

2.01

49.06

36.5

26.3

39.06

40.64

23.87

12054

115206

(3035941) MCH [Entitic mass]

12096

116507

2.01

48.99

35.6

25.7

30.31

30.33

0.59

12056

115248

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12096

116509

2.01

48.96

35.7

25.8

91.33

91.26

0.99

12056

115248

(40759836) Histone Ab [Presence] in Serum by Immunoblot

253

924

2.77

48.94

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

256

942

2.75

48.81

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

12096

116520

2.01

48.77

35.7

25.8

4.42

4.46

e12/l

12.48

11987

113723

(3010813) Leukocytes [#/volume] in Blood

12097

116534

2.01

48.75

35.8

25.9

6.89

6.73

e9/l

10.90

11985

113721

(3000475) Leukocytes [#/volume] in Synovial fluid

574

3007

1.95

47.57

1.7

1.6

10748.22

13827.29

e6/l

0.98

378

2096

(3039162) Centromere protein B Ab [Units/volume] in Serum

342

1471

2.36

47.10

1.2

1.3

63.35

60.25

u/ml

0.06

104

(4034850) Laboratory test

3593

0.23

47.06

6.9

10.4

—

(3003694) ABO and Rh group [Type] in Blood

3830

30966

1.34

46.04

1.4

—

(3036489) Thrombin time

737

4226

1.79

45.96

2.3

2.1

21.49

21.04

1.06

693

3747

(3007164) IgA [Mass/volume] in Serum or Plasma

2908

22576

1.37

45.37

1.6

1.5

2.38

2.45

g/l

1.11

1630

13807

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

826

4935

1.72

44.59

2.1

1.9

1.93

2.16

ug/l

0.21

779

4349

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2655

20362

1.39

44.51

3.9

3.4

0.81

0.82

mmol/l

3.46

2546

19148

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

666

3766

1.81

43.48

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

589

3211

1.88

43.24

2.9

2.6

199.31

197.00

0.24

557

3059

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1393

9541

1.52

42.68

3.6

4.0

1.24

1.23

mmol/l

9.70

1347

8176

(3021960) Folate [Moles/volume] in Serum or Plasma

4182

34532

1.32

42.55

1.8

1.7

20.19

20.26

nmol/l

0.12

3967

29163

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

484

2491

1.98

42.21

2.1

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

1110

7254

1.58

42.00

1.4

1.3

175.09

237.87

u/ml

2.04

1050

6706

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9391

86533

1.34

41.39

4.7

4.5

14.36

14.85

pmol/l

72.63

9161

79363

(3025941) Bacteria identified in Stool by Culture

950

6001

1.63

41.38

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

261

1061

2.49

40.74

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

159

498

3.22

40.43

3.2

3.5

0.72

1.42

5.66

159

498

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

741

4415

1.72

40.32

2.4

0.66

0.86

g/l

0.97

700

3758

(3036603) Volume of Urine

225

865

2.63

39.44

1.7

1.6

1936.87

1929.65

0.04

215

843

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

351

1646

2.16

39.33

1.1

177.72

7117.68

iu/ml

0.57

352

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3824

31478

1.31

38.93

2.6

2.4

2.60

2.85

mg/l

9.05

3483

27197

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1896

14062

1.41

38.04

4.6

4.4

241.99

244.23

u/l

0.20

1838

13308

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4448

37482

1.29

37.55

3.0

2.7

57.30

63.57

u/l

1.94

4320

34689

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

480

2564

1.91

37.50

1.6

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

221

868

2.57

37.11

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11009

104489

1.43

36.94

5.6

5.3

6.14

5.95

mmol/l

34.35

10700

95827

(3018333) Ribosomal P Ab [Presence] in Serum

218

856

2.57

36.63

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

601

3468

1.77

36.58

2.5

2.3

94.92

92.57

1.70

578

3350

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

622

3637

1.75

36.15

1.3

1.5

0.16

9.75

iu/ml

1.12

187

689

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

320

1501

2.16

35.86

1.1

2.08

2.96

0.69

215

(3048689) Calprotectin [Mass/mass] in Stool

1937

14568

1.39

35.57

2.5

2.3

124.62

136.03

ug/g

0.89

1705

11518

(3012501) Base excess in Blood by calculation

2526

0.20

35.55

2.7

4.1

2.62

2.57

mmol/l

0.04

1732

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11114

105799

1.44

35.42

5.7

5.1

1.44

1.48

mmol/l

22.93

10878

97968

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11169

106458

1.44

34.96

5.8

5.2

4.55

4.63

mmol/l

14.50

10918

99213

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2099

16061

1.37

34.56

7.2

6.0

1.06

1.04

mmol/l

2.23

2004

14913

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

467

2541

1.87

34.47

1.4

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2574

20338

1.33

34.27

2.1

2.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

505

2826

1.82

34.07

1.3

2.73

3.75

u/ml

0.30

190

(3000494) Fungus identified in Specimen by Culture

1884

14203

1.38

33.96

1.7

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

793

5028

1.62

33.86

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

517

2921

1.80

33.79

2.0

2.3

129.53

128.10

g/l

0.70

442

2219

(3038177) Helicobacter pylori Ab [Presence] in Serum

351

1746

2.04

33.70

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

436

2345

1.89

33.36

3.9

3.6

25.41

27.79

mg/l

0.84

354

1616

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3181

25967

1.30

33.35

1.4

1.3

1.54

1.76

u/ml

0.56

685

7019

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5248

45593

1.26

33.17

5.3

4.1

0.06

0.54

estimate

2.91

1166

10239

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4047

47348

0.79

32.94

2.0

1.9

1.37

1.35

mmol/l

0.53

3891

39401

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

228

3.97

31.58

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10790

102550

1.37

31.52

8.7

6.5

40.38

39.42

mmol/mol

22.41

10610

95662

(3003396) Base excess in Arterial blood by calculation

1860

14180

1.37

31.01

8.0

7.7

0.97

mmol/l

0.02

1527

11748

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1056

7290

1.49

30.68

1.3

64.61

52.51

au/ml

0.86

483

(40760892) CBC W Ordered Manual Differential panel - Blood

3079

25284

1.29

30.31

5.8

4.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

861

5714

1.54

30.13

1.8

1.7

1.56

g/l

0.06

799

4907

(3024891) Influenza virus A+B Ag [Presence] in Specimen

488

2808

1.77

29.98

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

322

1625

2.01

29.74

1.2

3.57

4.42

u/ml

0.66

147

745

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11281

108180

1.42

29.72

6.4

6.0

2.66

2.69

mmol/l

3.03

11029

100433

(3020630) Protein [Mass/volume] in Serum or Plasma

1423

10447

1.41

29.72

2.5

2.6

66.13

66.24

g/l

0.21

1367

9491

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2957

24234

1.29

29.40

3.1

2.46

mmol/l

1.13

2637

21747

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

531

2.79

29.20

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

559

3368

1.69

29.12

2.9

2.7

3.61

3.60

g/l

0.07

534

3219

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

324

1655

1.98

28.93

1.2

3.29

3.45

u/ml

0.06

125

595

(3021788) Differential panel - Synovial fluid

409

2258

1.84

28.85

1.7

1.5

—

1.00

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

683

4340

1.61

28.85

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1857

14301

1.35

28.81

8.1

7.7

12.51

12.35

kpa

0.65

1774

13777

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1857

14306

1.35

28.74

8.1

7.7

5.18

5.09

kpa

3.17

1774

13788

(40761535) Cells panel - Urine sediment

573

9062

0.61

27.95

3.1

3.5

—

1.75

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

8.39

27.83

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7181

65297

1.23

27.81

3.1

2.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4516

39128

1.24

27.55

4.3

4.2

9.00

8.60

mg/mmol

0.24

3449

23846

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

583

3614

1.64

27.21

1.3

71.93

36.42

u/ml

0.93

200

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

550

3359

1.67

27.21

1.4

1.3

14.59

6.31

u/ml

0.91

507

(3019977) pH of Arterial blood

1844

14310

1.34

27.03

8.1

7.7

7.41

7.42

1.18

934

7802

(3026389) Candida sp identified in Specimen by Organism specific culture

327

1718

1.93

26.92

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

1658

0.15

26.83

2.2

2.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3642

30893

1.25

26.69

2.9

2.8

341.48

341.57

umol/l

0.02

3386

27055

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

547

3361

1.66

26.44

1.3

16.98

4.05

u/ml

0.56

329

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

181

770

2.37

25.73

1.2

90.93

89.54

u/l

0.05

150

646

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

476

2847

1.70

25.49

1.2

3.01

3.91

1.18

343

(3003888) Timothy IgE Ab [Units/volume] in Serum

337

1832

1.86

25.01

1.1

2.58

4.62

u/ml

2.69

158

954

(3002179) Metamyelocytes/Leukocytes in Blood

1356

10155

1.38

24.90

4.4

4.3

0.52

0.74

3.26

317

3175

(3012494) Peanut IgE Ab [Units/volume] in Serum

246

3.47

24.68

1.0

1.1

0.68

5.09

u/ml

0.68

132

(3043410) Blood group antigens tested for on Red Blood Cells

291

3.25

24.54

2.4

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

327

1773

1.87

24.48

1.1

0.51

0.96

u/ml

1.57

131

784

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

175

751

2.35

24.42

1.2

26.49

25.12

u/l

0.09

146

613

(3003327) Ova and parasites identified in Stool by Light microscopy

624

4037

1.57

24.40

1.6

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1469

11196

1.35

24.08

2.3

378.12

379.98

nmol/l

0.13

1403

10355

(4146454) Self-monitoring of blood glucose

1292

0.09

23.99

2.9

2.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

756

5121

1.51

23.97

1.5

1.6

9.52

15.39

iu/ml

0.53

125

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

663

4370

1.55

23.87

2.4

2.3

509.56

605.33

ug/l

0.30

640

4138

(3043409) Potassium [Moles/volume] in Arterial blood

148

3379

0.43

23.76

3.3

4.3

4.02

3.88

mmol/l

2.77

134

3353

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

657

4349

1.54

23.20

1.8

1.6

21.45

18.29

u/ml

0.39

177

937

(3007916) DNA double strand Ab [Titer] in Serum

135

4.31

22.87

1.4

1.3

58.00

271.32

titre

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

240

3.39

22.71

2.0

2.4

20.90

177.31

ug/l

0.70

240

(3013139) Helicobacter pylori Ag [Presence] in Stool

1085

7989

1.39

21.98

1.3

—

(3027945) Reticulocytes/Erythrocytes in Blood

1799

14303

1.30

21.78

2.5

2.6

1.75

1.80

1.11

1695

12719

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

300

1655

1.83

21.30

5.9

6.5

11.98

12.05

mg/l

0.09

285

1529

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

566

2.44

20.88

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

566

2.44

20.88

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

139

579

2.42

20.81

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

155

3.88

20.62

2.1

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

359

2113

1.72

20.44

1.2

1.1

1.10

1.98

u/ml

1.39

171

1133

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

154

680

2.28

20.20

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

541

3551

1.55

19.86

2.0

1.7

0.24

g/l

0.12

514

3375

(3002619) Bacteria identified in Specimen by Culture

294

2.97

19.67

1.6

1.2

—

(36660697) Celiac disease serology panel - Serum

1187

9077

1.34

18.82

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

597

4054

1.50

18.69

2.8

3.2

0.28

0.36

iu/ml

7.49

309

2255

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

223

1172

1.92

18.47

1.2

1.1

96.05

96.69

0.14

209

1102

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

406

2.60

18.44

2.7

2.6

0.61

0.62

mmol/l

0.58

105

406

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

600

0.08

17.98

2.0

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1242

0.20

17.88

3.7

4.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

543

3657

1.51

17.70

2.0

1.6

1.19

1.20

g/l

0.31

518

3482

(4198724) Urine methamphetamine measurement

370

2.63

17.53

3.1

2.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

194

3.31

17.40

1.1

—

36.68

—

(3017569) Oxygen content in Arterial blood

147

679

2.18

17.36

2.0

2.3

15.44

15.87

0.79

147

679

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

400

2533

1.60

17.20

1.7

1.5

812.41

1233.22

e6/l

0.56

325

1997

(3016502) Oxygen saturation in Arterial blood

1586

12776

1.28

17.03

8.9

8.0

95.09

95.56

2.18

1528

12342

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

286

2.84

16.99

2.3

1.9

16.02

38.11

u/l

1.62

264

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

394

2497

1.60

16.89

1.4

16.54

29.75

e6/l

0.90

309

1837

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1045

7998

1.33

16.41

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

156

759

2.07

16.14

1.2

1.1

—

(3024263) Appearance of Synovial fluid

124

551

2.26

16.13

1.4

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

120

528

2.28

15.98

1.2

1.3

6.12

5.87

mmol/l

0.84

114

498

(3020874) Milk IgE Ab [Units/volume] in Serum

127

574

2.22

15.87

1.0

1.1

0.34

1.60

u/ml

1.28

183

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1927

0.39

15.86

1.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

987

7535

1.34

15.76

1.2

157.25

141.08

u/ml

0.48

278

2842

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

141

668

2.12

15.66

2.4

2.6

1061.57

1081.84

u/ml

0.03

141

656

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

173

884

1.97

15.64

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

206

1116

1.86

15.63

1.7

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

1031

0.18

15.56

2.6

3.0

165.90

54.89

mg/l

0.42

750

(40768797) Stomach Pathology biopsy report

1982

16574

1.23

15.21

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

156

780

2.01

15.02

1.3

1.2

82.27

81.53

0.06

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

358

2.52

15.01

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

118

531

2.23

14.93

1.2

1.1

3.25

3.50

iu/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1148

9018

1.30

14.92

3.3

2.9

10.31

10.51

g/l

0.80

1101

8336

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

3.32

14.84

6.1

6.2

21398.71

3968.08

iu/ml

—

(3019150) Specific gravity of Urine by Refractometry

3075

26925

1.19

14.49

3.6

4.4

1.39

1.19

kg/l

0.22

2702

17778

(3001964) Herpes simplex virus Ag [Presence] in Specimen

289

2.67

14.45

1.7

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

247

1451

1.72

14.30

2.9

2.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

529

3705

1.45

14.20

1.5

1.4

280.78

272.65

ug/g

0.42

358

2173

(1002224) Polysomnography panel

670

4893

1.39

14.20

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

2697

0.51

14.03

2.5

3.5

883.04

683.06

u/ml

0.10

116

2445

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

319

2012

1.60

14.02

1.7

1.5

154.30

151.84

au/ml

0.17

128

580

(4268621) Lupus anticoagulant assay

208

1172

1.79

13.94

2.2

2.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

172

916

1.89

13.82

2.4

2.0

1.09

1.67

u/field

1.76

114

485

(3001729) Color of Synovial fluid

4.23

13.58

1.1

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

471

3255

1.46

13.57

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

324

2.51

13.40

1.2

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1187

9551

1.27

12.71

4.3

2.7

64.90

65.08

ml/min/173m2

0.05

409

4113

(3045414) Leukocytes [Presence] in Urine

1411

11588

1.25

12.65

2.4

2.1

0.00

0.02

estimate

4.36

332

2252

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

840

10788

0.76

12.54

1.9

2.0

3.45

ratio

0.02

666

8349

(3015171) Extractable nuclear Ab [Units/volume] in Serum

629

4645

1.37

12.47

1.3

0.65

1.06

u/ml

0.60

401

(3003129) Base excess in Capillary blood by calculation

1441

0.38

12.47

2.0

2.3

2.44

0.55

mmol/l

1.95

1391

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

324

2.45

12.43

1.5

1.2

15.42

11.47

pmol/l

0.93

113

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

139

717

1.95

12.34

1.8

1.5

5.45

6.23

u/l

0.84

117

612

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

160

865

1.86

12.32

1.9

1.8

—

(21494755) Public health laboratory ask at order entry panel

665

8796

0.74

12.25

1.3

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

363

2.35

12.24

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4554

41548

1.15

12.19

3.7

3.6

2.36

mmol/l

0.30

4327

37635

(3006442) Creatine [Moles/volume] in Serum or Plasma

135

696

1.95

12.02

1.3

1.6

78.10

82.54

umol/l

0.90

135

696

(3026470) Cobalt [Mass/volume] in Blood

133

686

1.95

11.83

2.4

2.2

5.17

3.59

ug/l

0.76

127

635

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

532

3857

1.40

11.81

2.9

3.2

4.88

4.81

ratio

0.01

379

2231

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

257

1608

1.61

11.75

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

901

7075

1.29

11.71

1.9

1.33

1.32

g/l

0.01

859

6488

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

337

2246

1.51

11.67

1.7

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

898

7054

1.29

11.64

11.0

9.9

15.80

15.93

0.71

886

6810

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

363

2463

1.49

11.53

7.7

5.6

5083.06

1214.27

iu/ml

0.41

354

(21494815) CD4 cells/Lymphocytes in Specimen

166

929

1.80

11.47

2.1

2.3

39.73

39.27

0.14

166

909

(3028271) Lactate [Moles/volume] in Capillary blood

1909

0.48

11.38

1.6

1.9

1.77

1.68

mmol/l

0.30

1866

(3035637) Corticotropin [Mass/volume] in Plasma

249

1560

1.61

11.34

1.7

1.5

27.24

27.10

ng/l

0.02

249

1555

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

245

1529

1.61

11.34

1.2

1.1

122.97

117.02

1.99

224

1385

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

160

889

1.81

11.33

1.2

1.3

9.48

8.96

mmol/l

0.74

152

841

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

134

3.22

11.31

1.1

1.4

53.63

54.41

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

447

3169

1.43

11.30

1.9

2.1

12.12

11.80

mg/l

0.29

430

2955

(3051651) Icteric interference index of Serum or Plasma

126

650

1.95

11.23

3.2

3.5

0.66

0.94

index

3.64

126

635

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1428

11904

1.23

11.07

9.4

8.5

119.28

120.58

g/l

1.67

1391

11639

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

332

2232

1.50

11.05

1.7

1.4

20.18

18.83

u/ml

0.08

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

333

2243

1.50

10.99

1.3

1.2

112.31

315.22

titre

2.45

178

(3018405) Lactate [Moles/volume] in Arterial blood

264

4026

0.65

10.89

2.8

4.1

1.58

1.39

mmol/l

1.40

232

3966

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

143

780

1.84

10.77

1.4

12.64

12.83

umol/l

0.13

135

730

(3027231) Wheat IgE Ab [Units/volume] in Serum

177

2.83

10.59

1.0

1.1

1.20

2.31

u/ml

0.30

147

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

179

1053

1.71

10.44

1.6

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

352

2.25

10.38

1.8

2.0

1.69

1.82

ratio

0.28

345

(3008898) HLA-B27 [Presence]

486

3563

1.38

10.14

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

160

923

1.74

10.03

1.1

1.2

178.40

194.00

titre

0.08

150

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

928

7457

1.26

10.03

3.1

3.5

4.40

4.45

pmol/l

0.77

866

6654

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

4.32

10.02

1.1

11.34

24.15

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

294

1969

1.50

10.01

1.5

1.6

0.73

0.78

g/l

0.41

268

1513

(3034426) Prothrombin time (PT)

345

2.24

10.00

1.2

28.74

28.16

0.29

345

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

214

1335

1.61

9.98

1.2

1.3

7.33

7.48

mmol/l

0.34

164

1169

(3014599) Egg white IgE Ab [Units/volume] in Serum

110

567

1.95

9.88

1.0

1.1

3.16

1.17

u/ml

0.58

141

(3051611) Lipemic interference index of Serum or Plasma

192

1169

1.65

9.87

3.2

3.3

14.21

13.34

index

0.39

126

637

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

165

965

1.72

9.86

1.9

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

288

1933

1.50

9.72

4.0

2.7

464.20

1828.03

u/ml

—

117

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

464

0.19

9.72

3.1

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1992

17321

1.18

9.70

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

103

523

1.98

9.67

2.3

2.1

53.58

148.96

ug/min

1.06

124

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

309

2108

1.48

9.63

1.4

1.3

256.79

273.65

u/ml

0.48

215

1312

(40760888) Immunoglobulin light chains.free panel - Serum

398

2858

1.41

9.42

2.5

3.5

—

856.01

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

567

4311

1.33

9.36

2.9

3.4

44.88

47.26

mg/l

0.15

550

3645

(3034860) Kappa light chains.free [Mass/volume] in Serum

567

4314

1.33

9.31

2.9

3.4

57.94

66.36

mg/l

0.26

547

3646

(3012565) Volume of 24 hour Urine

598

0.18

9.24

1.4

2.2

1717.91

1917.08

0.30

530

(40768793) Breast Pathology biopsy report

187

2960

0.63

9.20

1.2

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1202

10029

1.22

9.20

2.2

2.4

7.46

7.18

ug/l

0.12

1124

8693

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

260

3824

0.67

9.03

1.3

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

616

7891

0.77

8.99

1.6

1.7

3.48

3.49

mmol/l

0.08

447

5451

(3010375) cycloSPORINE [Mass/volume] in Blood

475

1.99

8.99

29.6

29.3

103.48

112.96

ug/l

0.65

386

(3014271) Vancomycin [Susceptibility]

586

0.19

8.98

3.4

2.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

631

4901

1.30

8.95

2.0

1.8

6.20

7.15

iu/ml

0.36

159

1145

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

177

2.66

8.92

2.0

1.3

15.38

9.70

0.58

(3004809) Band form neutrophils/Leukocytes in Blood

296

2035

1.47

8.90

3.0

3.7

2.09

1.58

0.99

246

1831

(3017732) Neutrophils [#/volume] in Blood

1710

14787

1.18

8.85

3.2

3.3

4.42

4.52

e9/l

0.24

1674

12636

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

706

1.79

8.79

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

113

614

1.85

8.71

1.9

2.3

100.35

97.40

0.36

107

576

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3527

32184

1.13

8.67

5.8

5.7

4.36

3.09

ug/l

0.41

3337

29096

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

857

0.34

8.66

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

848

6862

1.25

8.64

3.8

3.6

2.95

1.84

mmol/l

13.22

598

5089

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

142

829

1.72

8.61

2.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

505

1.93

8.53

2.4

1.7

27.36

29.61

umol/l

1.63

473

(3012516) Albumin [Mass/volume] in Urine

4173

38505

1.13

8.51

3.6

3.5

47.41

46.96

mg/l

0.05

3159

24091

(3022493) Free Hemoglobin [Mass/volume] in Plasma

500

1.93

8.44

3.3

4.3

2557.33

465.84

mg/l

0.39

362

(3041672) Baker's yeast Ab [Presence] in Serum

4.16

8.44

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

637

4996

1.29

8.41

1.9

2.0

39.66

39.63

u/l

0.01

562

4428

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

592

0.22

8.39

2.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

592

0.22

8.39

2.2

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

710

5648

1.27

8.37

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

840

0.34

8.33

1.6

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

207

0.00

8.20

0.0

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

995

11936

0.82

8.14

3.1

3.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

232

1549

1.51

8.11

5.7

5.2

354.85

359.31

umol/l

0.19

207

1341

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.17

8.05

1.2

21.17

14.42

nmol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

440

1.96

7.99

2.2

2.4

—

(4195642) Thrombophilia screening test

228

1522

1.51

7.98

1.2

—

(3025577) Chromium [Mass/volume] in Blood

118

670

1.77

7.92

2.4

2.2

2.29

2.45

ug/l

0.19

105

561

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

954

7905

1.22

7.82

12.1

9.8

0.53

0.64

15.70

940

7859

(3027944) Amphetamines [Presence] in Urine

440

3327

1.33

7.61

2.2

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

267

1862

1.44

7.53

1.1

—

(3025130) Human papilloma virus identified in Specimen

230

1560

1.48

7.48

1.6

1.8

—

(3018572) Chloride [Moles/volume] in Blood

160

2494

0.64

7.44

6.5

6.9

104.49

105.06

mmol/l

0.63

144

2245

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

487

1.87

7.43

1.2

1.1

224.22

177.30

iu/ml

0.34

480

(3039000) Anion gap in Blood by calculation

160

2493

0.64

7.42

6.5

6.9

12.06

11.27

mmol/l

1.65

144

2243

(3023183) Ammonium ion [Moles/volume] in Plasma

349

2558

1.37

7.40

2.2

2.7

33.19

33.72

umol/l

0.15

315

2302

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

214

1434

1.50

7.39

1.1

5.10

3.39

eliau/ml

0.46

631

(3026250) Tacrolimus [Mass/volume] in Blood

496

1.86

7.35

48.3

40.0

7.34

7.20

ug/l

0.17

446

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

122

716

1.71

7.33

1.1

4.23

9.49

nmol/l

0.85

136

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

348

2556

1.37

7.29

1.4

1.3

3.94

3.77

mmol/l

1.88

333

2427

(1175426) CD3 cells/Lymphocytes in Blood

142

871

1.64

7.22

2.1

2.2

73.92

72.28

0.61

128

838

(3048929) Epstein Barr virus Ab [Presence] in Serum

428

3254

1.33

7.15

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

316

2.06

7.01

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3125

28610

1.12

7.00

3.8

4.0

0.00

0.36

1.40

294

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

386

2902

1.34

6.98

1.4

569.99

538.48

mg/l

0.25

376

2774

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

170

2.48

6.97

9.8

11.7

6.34

5.31

mmol/l

0.82

170

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1300

0.52

6.89

3.9

2.9

13.18

13.21

0.10

1281

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

763

9234

0.82

6.82

1.6

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

120

2.75

6.77

1.6

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

220

1513

1.46

6.72

1.3

0.18

0.20

nmol/l

0.87

177

1181

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.29

6.67

1.5

1.6

1.28

1.93

mg/l

0.38

(3000764) Benzodiazepines [Presence] in Urine

435

3358

1.31

6.55

2.2

2.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

494

1.81

6.53

2.6

2.0

56.22

63.93

ug/l

0.61

481

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1303

0.53

6.53

4.9

4.3

61.99

65.92

u/ml

0.06

1285

(40757373) Influenza virus identified in Isolate

207

2.28

6.50

1.9

1.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

227

2.21

6.44

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

459

0.24

6.28

2.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

459

0.24

6.28

2.7

2.0

—

(3016228) CD19 cells/cells in Blood

443

1.83

6.25

1.8

2.1

7.25

8.13

0.33

435

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1419

12421

1.16

6.23

1.9

1.7

1.52

1.47

1.94

1302

10787

(3003181) Sodium [Moles/volume] in Urine

320

2383

1.35

6.21

1.6

1.4

60.18

61.68

mmol/l

0.29

278

1904

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

387

1.89

6.21

1.1

1.2

0.32

0.30

g/l

0.91

309

(3020961) Endomysium IgA Ab [Titer] in Serum

643

5250

1.24

6.12

1.1

87.12

173.40

titre

1.28

141

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

208

2.22

6.01

1.3

1.2

89.75

72.27

0.53

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.15

6.00

1.5

1.6

2.41

1.69

mg/l

0.18

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.15

6.00

1.5

1.6

0.46

1.54

mg/l

1.17

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

131

828

1.59

5.98

1.4

1.3

1.58

1.83

u/ml

0.09

475

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

789

1.60

5.98

1.2

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1366

11966

1.16

5.94

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

431

3381

1.28

5.79

2.2

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

1541

0.60

5.72

1.2

1.3

—

(3004451) EKG impression Narrative

112

691

1.63

5.67

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1514

0.60

5.52

1.5

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

211

2.14

5.41

1.7

1.2

96.82

74.97

0.71

(3006462) Nitrate [Presence] in Urine

525

0.34

5.41

2.1

3.6

—

(3028300) Cannabinoids [Presence] in Urine

428

3390

1.27

5.35

2.2

2.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

496

1.72

5.34

2.0

1.9

149.62

158.76

0.52

467

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

143

2.38

5.28

2.8

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1520

0.62

5.27

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

950

8171

1.18

5.24

12.0

9.6

1.16

1.33

4.85

936

8126

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

257

1905

1.36

5.21

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

407

0.27

5.20

2.9

3.3

9.07

10.32

kpa

0.86

407

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

406

0.27

5.18

2.9

3.3

5.06

4.96

kpa

0.12

406

(3000919) Neutrophils/Leukocytes in Pleural fluid

311

1.90

5.17

1.9

1.4

16.67

21.15

0.65

281

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1523

0.62

5.14

1.5

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

127

2.44

5.10

1.5

1.1

15.16

20.94

u/l

1.30

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

246

1818

1.36

5.09

1.2

1.1

35.22

15.42

au/ml

2.38

394

(3005011) Chlamydia sp Ab [Titer] in Serum

141

2.34

4.97

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

394

3126

1.27

4.90

2.1

2.0

—

(4211845) Urine protein measurement

571

0.40

4.89

2.8

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1183

0.59

4.74

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

992

0.55

4.73

1.2

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

193

1389

1.40

4.73

3.0

3.5

7.23

14.45

nmol/l

0.65

186

1352

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

157

2.23

4.73

1.2

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.42

4.73

4.1

3.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

936

8110

1.17

4.73

3.9

3.7

5.24

5.15

kpa

2.16

917

7720

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

584

1.61

4.70

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

229

1697

1.36

4.70

1.1

0.63

1.45

u/ml

3.10

143

846

(3011985) Renin [Units/volume] in Plasma

237

1766

1.35

4.69

1.4

1.5

51.12

60.52

mu/l

0.37

222

1583

(3016038) Potassium [Moles/volume] in Urine

128

855

1.50

4.66

1.8

1.2

33.83

34.67

mmol/l

0.16

117

738

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

217

1597

1.37

4.65

1.1

1.47

1.53

g/l

1.46

197

1456

(3011412) CD3 cells [#/volume] in Blood

155

1079

1.44

4.59

2.3

2.4

1166.57

1171.55

e6/l

0.03

127

957

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

221

1640

1.35

4.51

1.3

318.79

326.54

pmol/l

0.11

200

1375

(3001019) Free T4 and TSH panel - Serum or Plasma

404

4993

0.80

4.50

1.6

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

236

1774

1.34

4.43

1.3

0.15

0.24

nmol/l

1.55

125

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

231

1731

1.34

4.43

1.3

4.19

3.15

nmol/l

0.10

223

1672

(3021387) Prolactin [Units/volume] in Serum or Plasma

388

3113

1.25

4.43

1.7

307.72

297.69

mu/l

0.25

360

2835

(3002256) Pathology report gross observation

1737

15766

1.12

4.36

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

171

1227

1.40

4.31

1.6

1.4

6.48

6.69

g/l

0.32

159

871

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

138

2.25

4.30

3.4

2.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

494

0.40

4.26

1.0

1.1

—

15.93

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.70

4.24

1.2

1.26

1.76

iu/ml

0.99

(3007566) Smooth muscle Ab [Titer] in Serum

410

3328

1.24

4.23

1.3

1.2

107.78

134.18

titre

0.46

328

(1617658) Protocol used for examination of sentinel lymph nodes

920

0.56

4.23

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

535

4466

1.21

4.20

1.7

0.30

0.32

mg/l

0.36

249

2037

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

358

2868

1.26

4.16

2.3

2.2

4705.00

5037.74

u/l

0.08

126

1079

(3024139) IgG subclass 3 [Mass/volume] in Serum

170

1227

1.39

4.15

1.6

1.4

0.41

g/l

0.06

158

869

(3028192) IgG subclass 2 [Mass/volume] in Serum

170

1228

1.39

4.14

1.6

1.4

2.72

2.90

g/l

0.82

157

874

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

314

1.79

4.12

1.1

1.2

91.52

86.73

0.21

158

(40768800) Prostate Pathology biopsy report

155

2146

0.72

4.06

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

451

1.64

4.05

1.8

2.1

31.62

31.23

0.07

451

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

727

0.52

4.04

1.2

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

142

2.19

4.03

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

651

7603

0.85

4.02

4.6

7.0

24.90

24.56

mmol/l

1.15

600

7295

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1278

0.64

4.02

1.5

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

700

1.50

3.93

1.2

1.1

21.68

18.87

u/ml

0.21

270

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

293

3693

0.79

3.93

1.6

1.7

3.78

4.68

mg/l

0.83

223

2772

(4062490) Immunoglobulin typing, IgG

166

1206

1.38

3.92

1.5

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

146

1038

1.41

3.92

1.8

1.5

38.11

30.13

1.64

614

(3000060) B lymphocytes [#/volume] in Blood

312

1.77

3.92

2.6

2.4

0.25

0.62

e9/l

0.70

152

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

320

1.75

3.89

1.1

85.38

87.17

0.10

154

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

136

957

1.43

3.87

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

103

688

1.50

3.83

2.1

2.0

9.46

7.94

mmol/l

3.14

103

688

(3020911) Cortisol [Moles/time] in 24 hour Urine

422

1.64

3.76

1.5

1.4

237.44

274.17

nmol/24h

0.08

422

(40762887) Creatinine [Moles/volume] in Blood

0.00

3.65

0.0

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

211

1.90

3.61

1.7

2.1

17.04

16.53

umol/l

0.10

211

(3001893) Eosinophils/Leukocytes in Pleural fluid

351

1.68

3.58

2.0

1.4

1.53

2.49

0.71

295

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

483

1.58

3.56

1.1

93.50

496.88

ng/l

1.44

126

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

253

3203

0.79

3.56

1.8

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

396

3269

1.22

3.55

1.7

2.0

83.36

6.36

iu/l

0.68

105

1332

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

180

1351

1.34

3.50

1.2

61.99

62.91

u/l

0.04

156

1175

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

253

3194

0.79

3.48

1.1

0.64

0.61

ratio

0.17

458

(3014148) Varicella zoster virus Ab [Titer] in Serum

184

1387

1.33

3.48

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

112

2.23

3.47

2.2

1.6

55.04

47.54

umol/l

0.41

112

(1001926) Buprenorphine [Presence] in Urine by Screen method

325

2635

1.24

3.47

2.3

2.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

519

1.54

3.44

1.1

1.0

0.23

1.01

u/ml

0.70

129

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

362

0.39

3.39

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

362

0.39

3.39

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

362

0.39

3.39

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

362

0.39

3.39

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

120

2.17

3.37

10.9

1.4

8.01

7.36

mmol/l

0.47

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.00

3.36

6.0

6.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

422

1.59

3.29

1.9

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.93

3.28

1.2

26.62

33.53

umol/24h

0.65

(3010503) CD19 cells [#/volume] in Blood

672

1.46

3.26

2.1

2.6

111.83

354.17

e6/l

1.33

653

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

129

2.10

3.22

1.1

2.27

8.94

u/ml

2.89

129

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.67

3.22

1.4

1.2

0.28

0.44

iu/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

617

1.48

3.21

1.1

1.2

0.53

0.59

ratio

1.41

363

(3023520) Reticulocytes [#/volume] in Blood

1237

11212

1.11

3.21

2.2

2.6

69.61

69.44

e9/l

0.05

875

8270

(3023511) Choriogonadotropin [Units/volume] in Urine

182

1390

1.31

3.18

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

578

1.49

3.17

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

236

1.78

3.15

1.6

1.7

161.77

121.05

au/ml

0.32

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

117

2.14

3.15

1.3

73.71

113.95

ug/l

1.02

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

104

2.21

3.14

1.2

1.87

1.67

umol/24h

0.36

104

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

208

1622

1.29

3.12

2.3

2.7

939.98

1159.56

u/ml

0.08

208

1604

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

114

812

1.41

3.11

1.1

9.11

8.74

iu/ml

0.06

192

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

631

1.46

3.08

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

601

0.55

3.08

1.1

—

(3009343) pH of Capillary blood

884

7878

1.13

3.08

3.9

3.7

7.41

7.42

0.92

845

6504

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.58

3.03

1.2

0.06

0.07

g/l

0.44

(3023323) Follitropin [Units/volume] in Serum or Plasma

576

4992

1.16

3.01

1.4

32.23

31.07

iu/l

0.36

512

4254

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

354

1.61

3.00

1.2

37.75

24.52

—

(40768443) Skin Pathology biopsy report

630

5500

1.15

2.99

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

242

1935

1.26

2.98

2.0

1.8

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

10.00

2.98

5.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

107

761

1.41

2.97

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

123

896

1.38

2.96

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

374

4450

0.84

2.96

1.8

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.63

2.96

2.5

2.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

419

1.55

2.93

1.9

1.4

67.69

65.32

0.27

344

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

604

0.56

2.93

3.1

4.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.27

2.93

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

357

1.60

2.91

4.8

—

(3011648) Oxygen content in Venous blood

168

1287

1.31

2.91

2.7

2.8

11.19

10.69

0.74

168

1280

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

137

1019

1.35

2.90

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.44

2.89

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.21

2.89

2.5

2.2

0.54

0.63

ug/l

0.95

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.21

2.89

1.6

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

163

1.90

2.88

1.6

1.5

7.40

277948.74

nmol/l

1.08

136

(43055442) Apixaban [Mass/volume] in Serum or Plasma

221

1.77

2.88

1.8

1.6

109.82

112.70

ug/l

0.07

191

(3025018) Bordetella pertussis Ab [Titer] in Serum

106

758

1.40

2.86

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

4247

40703

1.07

2.86

3.5

3.4

7.20

7.31

mmol/l

1.04

4063

34147

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.77

2.81

1.2

1.90

1.89

mg/l

0.01

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

165

1.88

2.79

1.1

1.30

8.61

u/ml

0.90

107

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

130

966

1.35

2.79

1.2

1.6

23.09

24.51

u/ml

0.11

186

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.64

2.79

1.0

1.1

0.01

0.07

u/ml

—

(3035880) pH of Pleural fluid

624

1.43

2.70

1.7

1.3

7.41

0.04

419

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

325

1.60

2.70

1.1

—

(44806420) Estimation of glomerular filtration rate

156

1197

1.31

2.70

2.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.45

2.68

1.0

2.57

1.44

u/ml

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.21

2.67

1.4

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

4.21

2.67

2.3

2.1

36.23

24.48

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

4.21

2.67

1.0

1.1

0.08

0.56

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

501

4343

1.16

2.65

2.3

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

199

0.35

2.65

4.9

7.0

11.59

10.39

—

199

(3023419) Bacteria identified in Sputum by Culture

197

1564

1.26

2.62

3.1

2.6

—

(3024932) HLA-DR beta [Type]

312

1.60

2.62

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

456

1.49

2.60

2.0

2.4

50.45

53.54

umol/l

0.38

394

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5249

54250

0.94

2.59

8.2

6.8

1.22

1.21

mmol/l

3.43

5155

50102

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1191

0.71

2.55

1.4

1.8

—

(3033099) Centromere Ab [Titer] in Serum

288

0.42

2.53

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

114

1522

0.75

2.51

1.4

1.3

35.40

30.79

u/l

0.69

100

1241

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

537

4703

1.15

2.49

2.4

2.0

—

(1616796) Gas panel - Central venous blood

322

2708

1.19

2.49

2.3

3.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

502

1.46

2.48

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

149

1152

1.30

2.47

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

349

1.55

2.46

1.4

1.2

41.88

382.38

ug/l

1.93

178

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.20

2.46

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

268

0.41

2.41

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

110

2.00

2.40

1.0

1.1

—

(3024471) HLA-A [Type]

320

1.56

2.39

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

111

1474

0.75

2.38

1.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.42

2.36

1.0

0.47

0.28

u/ml

0.30

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

171

2144

0.79

2.35

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

835

9221

0.90

2.34

2.0

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

152

1189

1.28

2.32

1.7

1.3

6.63

6.34

mmol/l

0.61

143

1098

(40765096) Chromosome analysis panel by Banding

358

0.50

2.31

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

389

1.49

2.26

3.4

2.9

32.58

28.14

umol/l

1.99

290

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

170

0.35

2.26

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

170

0.35

2.26

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.02

2.25

1.3

1.1

102.40

91.15

titre

0.31

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

539

1.41

2.23

2.5

1.9

167.28

131.21

umol/l

0.34

273

(3019309) Folate [Moles/volume] in Red Blood Cells

2203

20822

1.07

2.22

1.5

1.8

723.06

1181.30

nmol/l

236.75

1886

15690

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.41

2.19

1.1

0.73

0.24

u/ml

0.33

(3028308) Erythrocytes [#/volume] in Pleural fluid

168

1342

1.26

2.19

1.4

49112.24

58591.35

e6/l

0.23

109

727

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

288

1.56

2.18

1.0

0.31

0.74

u/ml

0.69

281

(3052592) Norovirus Ag [Presence] in Stool

212

0.42

2.17

2.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

245

2039

1.21

2.17

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

193

1574

1.23

2.10

1.6

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

564

1.39

2.07

1.9

1.5

3.64

3.91

0.05

119

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

108

824

1.31

2.03

1.2

1.3

72.00

71.07

titre

—

(44790047) Parainfluenza type 1 nucleic acid detection

184

1499

1.23

2.03

1.9

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

146

0.34

2.00

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

154

1234

1.25

1.98

1.4

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

325

0.52

1.98

3.2

3.1

2.22

2.02

ratio

0.25

295

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

298

3469

0.86

1.94

1.4

1.7

—

(44806118) Parainfluenza type 4 nucleic acid detection

183

1499

1.22

1.94

1.9

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

183

1499

1.22

1.94

1.9

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

183

1499

1.22

1.94

1.9

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1609

15130

1.07

1.89

1.7

1.6

—

(3014891) Appearance of Pleural fluid

158

1.71

1.88

1.4

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

139

0.36

1.87

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

208

1733

1.20

1.87

1.7

1.4

31.49

32.41

g/l

0.52

190

1564

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.86

0.0

1.0

—

8.37

—

(3037756) Immunofixation for Serum or Plasma

305

2627

1.17

1.86

1.4

1.7

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.86

1.86

1.0

1.1

0.24

0.21

g/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.08

1.86

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1010

0.74

1.85

1.4

1.5

65.89

59.79

ug/l

0.52

1010

(3038026) Centromere Ab [Units/volume] in Serum

941

0.73

1.85

1.2

9.64

52.18

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

212

1773

1.20

1.83

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

212

1773

1.20

1.83

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

733

1.31

1.83

2.4

2.6

0.67

e9/l

0.00

703

(3048879) Bone marrow aspiration report

316

0.54

1.83

1.1

1.8

—

2.00

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

410

3613

1.14

1.83

4.8

3.6

1.59

1.58

mg/l

0.12

366

3291

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

110

856

1.29

1.83

1.2

37.27

40.41

mg/l

0.43

101

730

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

359

1.45

1.82

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.12

1.81

1.1

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

189

2272

0.83

1.81

1.8

1.9

191.35

201.03

pmol/l

0.73

172

2147

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.57

1.80

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

4779

46438

1.05

1.75

2.3

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

237

2780

0.85

1.73

1.5

1.6

1071.96

1006.09

mu/l

0.48

207

2300

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

620

1.32

1.70

1.3

1.2

—

(40758358) Immune stain study

0.00

1.69

0.0

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

390

1.41

1.69

1.5

1.9

7535.94

17468.67

e6/l

0.76

195

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.95

1.69

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

183

1524

1.20

1.69

1.5

1.4

2674.22

3274.98

e6/l

0.23

124

1048

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

108

849

1.27

1.68

1.2

1.3

2298.00

338.45

titre

—

(3010838) Calcium [Moles/time] in 24 hour Urine

254

2179

1.17

1.67

1.6

1.9

4.62

4.96

mmol/24h

0.95

236

1929

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.16

1.66

2.2

1.1

2.03

1.88

g/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.58

1.65

1.0

1.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.80

1.65

1.4

1.9

171.14

239.65

nmol/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

228

1.54

1.64

1.1

0.78

0.64

umol/24h

0.75

101

(40768795) Lymph node Pathology biopsy report

1225

0.78

1.63

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

538

1.34

1.63

1.1

1.3

135.58

161.42

mmol/24h

2.02

538

(3008536) Aspergillus sp Ab [Presence] in Serum

237

1.52

1.61

2.2

1.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.82

1.56

1.1

1.0

0.76

4.55

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

380

4272

0.89

1.56

2.3

2.7

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.27

1.55

1.0

6.11

7.55

u/ml

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

122

1.72

1.54

1.1

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

1.51

0.0

1.0

—

0.08

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

1.51

0.0

1.1

—

0.04

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

162

1.61

1.48

4.1

2.5

1.41

1.32

mmol/l

0.09

108

(3024522) Salmonella sp identified in Specimen by Organism specific culture

130

1581

0.82

1.47

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

122

1492

0.82

1.46

1.4

1.5

1.25

1.19

ratio

0.36

885

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

122

1492

0.82

1.46

1.4

1.5

0.94

ratio

0.06

882

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

122

1490

0.82

1.44

1.4

1.5

1.13

1.14

ratio

0.03

880

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

378

0.63

1.44

1.4

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.12

1.44

4.5

4.2

12.35

12.83

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.03

1.43

1.0

1.1

0.01

0.08

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.79

1.42

1.1

1.0

0.02

0.25

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

157

1314

1.20

1.42

2.5

3.6

51.92

57.83

2.30

112

1142

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

693

6389

1.09

1.41

2.9

3.8

61.78

70.15

u/ml

0.15

672

6161

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

203

2363

0.86

1.41

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1021

0.78

1.41

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1021

0.78

1.41

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1021

0.78

1.41

1.5

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

828

1.25

1.39

1.1

272.57

266.39

mg/l

0.12

737

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.89

1.38

1.1

1.0

—

(44806071) Cardiolipin IgM antibody measurement

142

1.62

1.38

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

342

3046

1.13

1.37

1.3

239.09

219.12

miu/ml

0.39

120

1353

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.33

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

754

0.75

1.33

1.2

1.5

—

(3028433) Virus identified in Specimen by Culture

381

0.66

1.31

1.1

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

1.31

0.0

1.0

—

10855.83

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

282

0.60

1.29

1.4

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.35

1.29

1.0

1.1

26.72

8.29

mg/l

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

130

1555

0.83

1.27

1.7

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

140

1174

1.19

1.27

1.2

1.3

1.28

1.50

nmol/l

2.11

128

1056

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

766

1.24

1.27

1.1

—

0.62

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

471

0.70

1.25

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

279

0.61

1.25

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

126

1049

1.20

1.24

5.4

5.3

28.74

109.59

u/ml

3.41

337

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

157

0.51

1.24

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

346

1.36

1.23

1.1

—

(3044007) Cell count panel - Peritoneal fluid

389

1.34

1.23

1.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.91

1.22

1.1

1.0

7.10

7.45

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

374

0.67

1.22

1.2

—

(3022313) Gas panel - Capillary blood

506

5512

0.91

1.20

4.1

3.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

110

908

1.21

1.20

1.1

302.18

289.00

mg/l

1.24

825

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

140

1.57

1.19

1.4

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

1002

1.20

1.17

1.1

1.2

103.37

110.95

pmol/l

0.89

120

1002

(3014133) Dog dander IgE Ab [Units/volume] in Serum

174

1501

1.16

1.1

3.04

3.33

u/ml

0.09

732

(3033086) Enterovirus Ab [Titer] in Serum

0.00

1.16

0.0

1.0

—

(3037121) Protein [Mass/volume] in Urine

368

4061

0.90

1.16

2.7

3.3

257.26

442.62

mg/l

3.12

216

1764

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

136

1603

0.85

1.16

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

1.16

0.0

1.3

—

1.37

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.73

1.14

2.1

2.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

166

1.51

1.14

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

1.14

0.0

1.1

—

1.36

—

(3049717) Cytology report of Urine Cyto stain

480

4406

1.09

1.13

2.3

2.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

267

1.39

1.12

1.2

292.90

296.87

pmol/l

0.03

193

(3023487) Leukocytes [#/volume] in Peritoneal fluid

458

1.29

1.11

1.7

2.0

2510.98

3770.66

e6/l

0.18

300

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.96

1.11

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.71

1.11

1.1

1.0

0.22

0.88

u/ml

—

(40768446) Kidney Pathology biopsy report

450

1.29

1.10

2.0

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

395

3601

1.10

1.09

1.3

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

0.01

0.04

u/ml

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

1.73

1.08

1.1

1.3

1.22

1.09

ml/s/173m2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2503

25858

0.96

1.08

4.0

4.7

22.75

22.08

1.23

1267

13041

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

417

1.30

1.06

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

637

0.77

1.06

1.3

168.46

180.20

pmol/l

0.24

637

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

542

1.26

1.05

1.2

1.3

46.86

63.46

—

(3019832) Treponema pallidum Ab [Presence] in Serum

821

7725

1.07

1.04

1.5

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

106

887

1.20

1.04

1.9

1.4

14.06

12.86

u/l

0.74

850

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

606

1.24

1.03

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

606

1.24

1.03

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

606

1.24

1.03

1.6

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.96

1.03

1.1

240.67

280.72

nmol/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

607

1.24

1.02

1.6

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

283

2548

1.11

1.01

2.3

2.7

16.20

16.23

0.06

277

2501

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

311

0.67

1.01

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.69

1.01

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.89

1.01

1.4

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

351

1.31

1.00

1.4

1.3

137.27

130.22

nmol/l

0.10

253

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

2352

1.12

0.99

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

791

1.20

0.99

1.0

794.89

720.18

ng/l

0.90

539

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

585

0.77

0.99

1.0

1.1

1306.84

1547.86

miu/ml

1.23

585

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

793

8413

0.94

0.99

1.9

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

189

1.43

0.98

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

447

0.74

0.97

2.3

1.9

170.20

45287.93

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

794

1.20

0.96

1.0

28.80

42.67

ng/l

6.92

547

(3040151) Glucose [Moles/volume] in Capillary blood

119

1391

0.85

0.96

10.0

10.5

8.22

7.40

mmol/l

1.63

104

1166

(3038071) Oxygen [Partial pressure] in Mixed venous blood

259

0.66

0.95

3.9

7.3

5.79

5.37

kpa

0.32

259

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

233

1.37

0.95

5.1

5.6

110.66

55.73

u/l

0.51

226

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

136

1571

0.86

0.95

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1650

17135

0.96

0.93

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

789

1.19

0.92

1.0

306.99

324.98

ng/l

0.12

553

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

431

0.74

0.92

1.0

1.1

107.59

94.49

1.32

341

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

427

1.27

0.92

1.1

1.2

—

(40768441) Liver Pathology biopsy report

104

881

1.18

0.92

1.2

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

136

1178

1.16

0.91

1.1

—

8.57

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.14

0.91

1.5

2.9

—

(3012898) Urea [Moles/volume] in Urine

126

1.51

0.91

1.3

145.21

160.95

mmol/l

0.24

107

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

114

1329

0.86

0.90

1.5

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

110

1.55

0.90

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

663

1.21

0.90

1.4

0.94

1.26

nmol/l

3.09

490

(3005033) Fetal Nuchal fold Thickness US

104

1220

0.85

0.89

1.4

1.5

1.13

1.26

2.59

858

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

655

1.21

0.89

2.4

2.7

46.82

39.19

1.48

381

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

563

0.78

0.88

18.5

14.3

807.59

3138.39

nmol/l

0.50

541

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

127

1.50

0.88

1.5

1.3

73.14

74.45

0.07

105

(3042517) Benzodiazepines panel - Urine

1.65

0.87

1.9

2.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

283

3108

0.91

0.87

1.7

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

134

1167

1.15

0.85

1.4

1.3

280.25

376.63

u/l

2.17

126

1098

(40758292) HTLV I+II Ab panel - Serum

216

0.65

0.85

1.5

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.67

0.85

1.0

1.1

0.03

0.22

u/ml

1.07

(3028717) Thiamine [Mass/volume] in Blood

170

1.41

0.85

1.1

1.2

65.54

64.31

ug/l

0.16

170

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

790

0.82

0.84

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

214

1.36

0.82

1.0

—

(3020491) Glucose [Moles/volume] in Blood

782

1.18

0.81

1.2

2.0

6.77

6.84

mmol/l

0.08

548

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2433

24999

0.97

0.80

1.8

1.7

402.70

33028939.95

pmol/l

18.27

2229

20667

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

301

2762

1.09

0.79

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

317

0.73

0.79

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.79

0.0

1.4

—

36.81

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

115

1.48

0.76

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

530

1.21

0.76

4.1

5.4

41.56

9063.84

u/ml

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.64

0.75

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

778

0.83

0.74

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

929

0.85

0.74

1.1

1.3

2.10

2.15

mmol/l

0.15

877

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

369

0.76

0.73

1.3

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

107

0.56

0.72

1.2

1.1

0.12

0.03

u/ml

—

107

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.61

0.72

1.3

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

295

2720

1.09

0.72

1.3

1.4

11.32

11.25

u/l

0.03

254

2160

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

288

0.73

0.72

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

109

0.55

0.72

1.3

1.1

5.95

6.11

mmol/l

—

109

(40768806) Pleura Pathology biopsy report

148

1318

1.12

0.71

1.6

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

0.06

0.02

u/ml

—

(4035726) Immunohistochemistry procedure

1020

10624

0.96

0.70

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

118

1.44

0.69

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

0.59

0.67

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

180

0.67

2.8

2.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

311

1.25

0.67

1.4

1.3

16.37

16.67

umol/l

0.18

274

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.79

0.66

1.0

1.1

2.40

3.14

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

102

893

1.14

0.65

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

126

1119

1.13

0.65

2.3

2.4

33.81

25.89

iu/ml

—

136

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1963

19110

1.03

0.65

3.1

3.3

0.72

0.79

ug/l

2.24

1511

12792

(3044927) Protein electrophoresis panel - Urine

107

1214

0.88

0.65

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

113

1277

0.88

0.64

1.5

—

(3000012) Reticulocyte production index

197

1797

1.10

0.63

1.6

2.1

0.94

0.90

0.33

154

1202

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

1305

1.11

0.61

1.1

0.10

0.28

u/ml

1.21

434

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

164

1488

1.10

0.60

1.2

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

151

0.66

0.59

1.0

1.3

—

87.31

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.54

0.59

2.3

8.4

101.00

104.58

g/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.59

0.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

131

1.37

0.59

1.4

1.2

0.03

0.43

u/ml

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

113

0.62

0.58

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

557

1.17

0.57

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

1121

1.12

0.57

1.4

120957.57

162523.89

e6/l

0.25

736

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

616

0.84

0.57

1.1

1.2

1.05

1.06

ratio

0.30

500

(3024869) Neuronal Ab [Presence] in Serum

241

0.75

0.56

1.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

755

1.14

0.56

2.5

2.6

415.07

510.73

e6/l

1.63

616

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.57

0.56

1.0

1.1

5.60

12.20

u/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

241

2595

0.93

0.55

3.3

0.87

0.82

nmol/l

0.98

215

2067

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

681

1.15

0.55

1.2

1.1

—

1.30

—

(3047189) Immunofixation for 24 hour Urine

580

0.84

0.54

1.5

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

0.66

0.54

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

598

1.15

0.54

1.1

1.05

1.12

u/l

0.62

254

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

145

1594

0.91

0.54

1.4

1.5

58.89

60.03

ug/l

0.13

129

1314

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

304

2850

1.07

0.53

1.5

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

637

1.15

0.53

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

305

0.79

0.52

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.43

0.52

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

378

1.19

0.51

1.1

1.2

35.30

39.70

g/l

1.12

182

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

135

0.67

0.51

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

509

0.84

0.49

1.5

1.9

39.93

40.12

g/l

0.09

509

(3042951) Complement C1q Ab [Units/volume] in Serum

1.56

0.48

1.0

1.1

—

23.30

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.45

0.48

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

114

1035

1.10

0.45

2.4

2.0

16.00

7.47

umol/l

1.20

750

(21494890) Protein electrophoresis panel - 24 hour Urine

115

1264

0.91

0.45

1.9

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

210

1.24

0.44

1.1

40.59

34.18

iu/ml

0.17

210

(3022475) Manganese [Moles/volume] in Blood

1.45

0.44

1.0

1.3

0.14

0.17

umol/l

—

(3017509) Phencyclidine [Presence] in Urine

1.37

0.43

1.2

1.6

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.61

0.43

1.0

1.1

268.00

244.23

pmol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

142

1539

0.92

0.42

1.4

0.23

0.34

nmol/l

3.23

113

1115

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.56

0.42

3.8

9.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

103

1131

0.91

0.41

2.4

3.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.40

0.0

2.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

423

0.85

0.40

1.5

1.7

2.94

1.66

u/ml

—

115

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

205

0.78

0.40

1.9

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

512

1.13

0.39

1.4

1.3

4.21

4.28

umol/l

0.06

450

(3034614) HLA Ag [Interpretation]

0.00

0.39

0.0

1.4

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.39

0.0

1.2

—

1.58

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

5.6

—

0.18

—

(3017704) Immunofixation for Urine

654

0.89

0.38

1.2

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.34

0.38

1.0

1.5

282.78

319.22

umol/24h

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.39

0.36

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.33

0.35

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.33

0.35

3.4

2.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

179

0.78

0.35

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

179

0.78

0.35

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

179

0.78

0.35

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

1.37

0.34

1.3

1.2

100.00

82.58

umol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

115

1239

0.93

0.33

1.4

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

242

0.83

0.32

2.0

3.4

45.73

124.65

ng/l

—

110

(3041918) Cholesterol [Moles/volume] in Pleural fluid

238

1.18

0.32

1.4

1.2

1.88

1.56

mmol/l

0.58

146

(3022145) Colonoscopy Study observation

1384

13583

1.02

0.31

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

162

1526

1.06

0.31

2.1

2.4

1.14

1.17

g/24h

0.07

106

888

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

128

1197

1.07

0.30

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.30

0.30

1.6

—

0.07

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

378

0.87

0.30

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

130

0.77

0.29

1.1

1.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.23

0.29

1.3

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.23

0.29

15.1

8.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

151

1424

1.06

0.28

1.1

3.37

4.35

u/ml

0.26

630

(3000093) Morphology [Interpretation] in Blood Narrative

124

1163

1.07

0.28

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

896

0.93

0.27

1.3

1.5

2.01

3.76

ug/l

3.97

738

(3051339) Copper [Moles/volume] in Blood

1.23

0.27

1.3

1.1

15.18

16.77

umol/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

364

0.88

0.27

2.6

2.5

1.08

1.15

ug/l

0.12

345

(3017446) Testosterone [Moles/volume] in Serum or Plasma

808

8263

0.98

0.27

2.5

2.3

11.67

13.02

nmol/l

4.48

738

7419

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.68

0.26

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

121

1285

0.94

0.26

1.2

72.83

36.72

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

192

0.83

0.25

1.6

1.2

0.63

1.61

mmol/l

—

130

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.23

0.25

1.2

—

(4212803) Bone marrow aspirate examination

105

1.24

0.24

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

676

1.08

0.24

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

255

0.86

0.24

1.0

1.2

—

421.82

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.73

0.24

4.0

5.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

174

1823

0.95

0.24

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

264

0.87

0.23

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

125

0.80

0.23

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

907

0.94

0.22

1.5

1.2

13.67

14.69

u/l

0.15

828

(4133840) Spirometry

267

1.12

0.21

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.19

0.21

1.0

1.1

0.01

0.61

u/ml

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.21

0.0

1.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.21

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

335

1.10

0.20

1.3

1.5

15.54

13.48

g/l

0.85

254

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

1549.29

—

(4281824) Cell count and differential, peritoneal fluid

146

1396

1.05

0.20

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

860

1.06

0.19

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.15

0.19

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.15

0.19

1.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

137

1.17

0.18

10.0

10.4

0.53

0.33

umol/l

0.48

125

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4507

44827

1.01

0.17

4.4

3.9

47.98

73.95

ng/l

1.25

3328

31874

(3035320) C reactive protein [Mass/volume] in Body fluid

942

1.05

0.17

3.2

2.8

25.82

29.16

mg/l

0.35

685

(3032352) Blasts [#/volume] in Cerebral spinal fluid

131

0.84

0.17

3.1

2.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

138

1436

0.96

0.16

1.7

1.6

55.31

58.13

0.35

894

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.79

0.15

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.79

0.15

1.7

4.0

—

0.00

estimate

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

178

1.12

0.15

1.4

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1198

11850

1.01

0.14

2.4

2.3

0.22

0.21

g/l

6.96

1101

11057

(3041806) Other cells [#/volume] in Blood by Manual count

202

0.89

0.14

1.8

1.6

0.46

0.49

e9/l

0.33

202

(21494434) Karyotype in Bone marrow

109

1047

1.04

0.14

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.83

0.13

1.0

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.82

0.13

1.0

2.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.82

0.13

1.3

1.0

—

15.81

iu/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

211

0.90

0.13

1.3

1.4

—

3459.00

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

294

2999

0.98

0.12

1.3

—

(3008295) Osmolality of Serum or Plasma

135

1391

0.97

0.11

1.5

1.4

276.28

277.43

mosm/kgh2o

0.20

105

1041

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

572

1.05

0.11

2.2

1.7

3.87

5.68

nmol/l

0.38

472

(3045142) Bone marrow Pathology biopsy report

140

1360

1.03

0.11

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

322

0.93

0.11

1.6

1.7

8.68

9.17

ug/l

0.35

322

(3013166) Neutrophils/Leukocytes in Synovial fluid

321

1.06

0.09

1.3

45.99

55.78

0.70

269

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.04

0.08

1.0

1.1

—

4.11

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

118

1154

1.02

0.07

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

186

1891

0.98

0.07

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

559

0.97

0.06

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

315

0.95

0.06

1.1

1000.00

923.88

titre

0.18

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

722

1.03

0.05

7.6

6.7

57.62

127.15

ug/l

0.58

458

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

293

0.96

0.05

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

723

1.02

0.05

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

248

1.05

0.05

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

199

1.06

0.04

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

360

3573

1.01

0.04

4.4

5.9

1.46

1.31

mmol/l

1.77

341

3169

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

109

1073

1.02

0.04

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

467

1.03

0.04

1.3

1.2

8.71

11.09

mm/h

0.99

467

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

149

0.94

0.03

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

214

2124

1.01

0.02

1.5

1.3

60.91

35.16

u/l

0.77

203

1832

(3020191) Ethanol [Moles/volume] in Serum or Plasma

902

0.99

0.02

1.4

1.64

1.18

promille

2.44

709

(3002331) Protein [Mass/volume] in Peritoneal fluid

291

1.03

0.02

1.4

217.65

26.56

g/l

0.50

225

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

381

1.02

0.02

1.3

1.7

454.61

391.25

pmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

136

1368

0.99

0.01

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

284

2831

1.00

0.01

1.1

5.34

8.01

eliau/ml

0.57

326

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

535

5359

1.00

0.01

1.8

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

0.96

0.00

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

786

0.99

0.00

2.5

2.7

237.10

226.84

e6/l

0.13

672

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

140

1397

1.00

0.00

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.05

0.00

2.1

1.4

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

142

0.99

0.00

5.6

6.2

9.00

7.77

0.36

142

(40761995) Spermatozoa Progressive [#/volume] in Semen

142

0.99

0.00

2.8

3.1

36.29

43.96

0.80

142

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.49

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

39.00

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

16.50

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.17

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.92

0.00

1.6

1.1

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.4

—

10.71

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.01

-0.00

1.3

1.2

38.25

1280.65

u/l

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

248.50

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

10403.33

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.88

-0.00

15.4

4.4

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.88

-0.00

1.2

1.6

158.00

568.05

nmol/l

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_SPEECH_THERAPY – Speech therapy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Speech therapy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Speech therapy (Z21_SPEECH_THERAPY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints